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Abstract
Modeling continuous-time physiological processes that manifest a patient’s evolving clinical
states is a key step in approaching many problems in healthcare. In this paper, we develop
the Hidden Absorbing Semi-Markov Model (HASMM): a versatile probabilistic model that
is capable of capturing the modern electronic health record (EHR) data. Unlike exist-
ing models, the HASMM accommodates irregularly sampled, temporally correlated, and
informatively censored physiological data, and can describe non-stationary clinical state
transitions. Learning the HASMM parameters from the EHR data is achieved via a novel
forward-filtering backward-sampling Monte-Carlo EM algorithm that exploits the knowl-
edge of the end-point clinical outcomes (informative censoring) in the EHR data, and
implements the E-step by sequentially sampling the patients’ clinical states in the reverse-
time direction while conditioning on the future states. Real-time inferences are drawn via a
forward-filtering algorithm that operates on a virtually constructed discrete-time embedded
Markov chain that mirrors the patient’s continuous-time state trajectory. We demonstrate
the prognostic utility of the HASMM in a critical care prognosis setting using a real-world
dataset for patients admitted to the Ronald Reagan UCLA Medical Center. In particular,
we show that using HASMMs, a patient’s clinical deterioration can be predicted 8-9 hours
prior to intensive care unit admission, with a 22% AUC gain compared to the Rothman
index, which is the state-of-the-art critical care risk scoring technology.
Keywords: Hidden Semi-Markov Models, Medical Informatics, Monte Carlo methods.
1. Introduction
Modeling the clinical conditions of a patient using evidential physiological data is a ubiq-
uitous problem that arises in many healthcare settings, including disease progression mod-
eling (Schulam and Saria (2015); Mould (2012); Wang et al. (2014); Jackson et al. (2003);
Sweeting et al. (2010); Liu et al. (2015)) and critical care prognosis (Moreno et al. (2005);
Matos et al. (2006); Yoon et al. (2016); Hoiles and van der Schaar (2016); Alaa et al. (2016)).
Accurate physiological modeling in these settings confers an instrumental value that mani-
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Figure 1: An episode of the diastolic blood pressure measurements (as recorded in the EHR) for
a patient hospitalized in a regular ward for 50 days and then admitted to the ICU after the ward
staff realized she is clinically deteriorating. Measurements are censored in accordance with the ICU
admission time.
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Figure 2: An episode of the systolic blood pressure measurements for a patient hospitalized in a
regular ward for 6 days and then discharged home by the ward staff. Measurements are missing in
a 24-hour period during the patient’s stay in the ward.
fests in the ability to provide early diagnosis, individualized treatments and timely interven-
tions (e.g. early warning systems in critical care hospital wards (Yoon et al. (2016)), early
diagnosis for Scleroderma patients (Varga et al. (2012); Alaa and van der Schaar (2016)),
early detection of a progressing breast cancer (Bartkova et al. (2005)), etc). Physiolog-
ical modeling also confers an epistemic value that manifests in the knowledge extracted
from data about the progression and severity phases of a disease (Stelfox et al. (2012))), or
the short-term dynamics of the physiological behavior of critically ill patients (Li-wei et al.
(2013)).
The recent availability of data in the electronic health records (EHR)1 creates a promis-
ing horizon for establishing rich and complex physiological models (Gunter and Terry (2005)).
Modern EHRs comprise episodic data records for individual (anonymized) patients; every
patient’s episode is a temporal sequence of clinical findings (e.g. visual field index for Glau-
1. A recent data brief from the Office for National Coordinator (ONC) for healthcare technology shows
that the adoption of EHR in US hospitals exhibited a spectacular increase from 9.4% in 2008, 27.6% in
2011, to 75.5% in 2014 (Charles et al. (2015)).
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coma patients (Liu et al. (2015)), CD4 cell counts for HIV-infected patients (Guihenneuc-Jouyaux et al.
(2000)), etc), lab test results (e.g. white cell blood count for post-operative patients under
immunosuppressive drugs (Cholette et al. (2012)), etc), or vital signs (e.g. blood pressure
and O2 saturation (Yoon et al. (2016))). The time span of these episodes may be as short
as few days in short-term hospitalization episodes (e.g. patients with solid tumors, hemato-
logical malignancies or neutropenia who are hospitalized in regular wards before or after a
surgery (Kause et al. (2004); Hogan et al. (2012); Kirkland et al. (2013))), or as long as few
years in longitudinal episodes (e.g. chronic obstructive pulmonary disease may evolve from
a mild Stage I to a very severe Stage IV over a time span of 10 years (Pedersen et al. (2011);
Wang et al. (2014))). In this paper, we develop a versatile physiological model that fits a
wide spectrum of healthcare settings, providing means for data-driven clinical prognosis.
In the next Subsection, we expose our modeling rationale and list the modeling challenges
posed by the structure of modern EHR data. We conclude this Section by summarizing our
contributions in Subsection 1.2.
1.1 Modeling Rationale and Challenges
1.1.1 Rationale
Previous physiological models have branched into two different modeling paths with re-
spect to the way a patient’s clinical states are defined. One strand of literature adopts fully
observable models; these models assume that clinical states are quantifiable via observable
clinical markers or disease severity measures (e.g. PFVC in Scleroderma (Schulam and Saria
(2015)), GFR in kidney disease (Eddy and Neilson (2006)), etc). Another strand of litera-
ture adopts latent variable models, which assume that clinical states are latent and manifest
only through proximal, noisy physiological measurements. Table 1 lists some notable pre-
vious works that fall under each modeling category.
Table 1: Modeling methodologies in previous works.
Methodology Previous Works
Fully observable models • HIV (Dessie (2014); Foucher et al. (2005)) • Chronic
kidney diseases (Eddy and Neilson (2006)) • Scleroderma
(Schulam and Saria (2015)) • ICU (Ghassemi et al.
(2015)).
Latent variable models • Alzheimer (Chen and Zhou (2011)) • HIV
(Guihenneuc-Jouyaux et al. (2000)) • Glaucoma (Liu et al.
(2015)) • Comorbidities (Wang et al. (2014)).
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Our modeling choice is to go with a latent variable model. The rationale behind this
choice is explicated as follows.
• In a wide range of problems, a concrete clinical marker that can be directly used as a
surrogate for the patient’s true clinical condition is available. This is especially true
in critical care settings where no solid definition or measure of a “clinical state” exists
(Li-wei et al. (2013)). Previous works that adopted a clinical risk score as a surrogate
for the clinical state in critical care settings have found that other physiological fea-
tures, when augmented with the clinical risk score, still hold a significant predictive
power with respect to end-point clinical outcome (Ghassemi et al. (2015)). This im-
plies that a clinical risk score or a severity of illness measure (such as APACHE II,
SAPS and SOFA (Knaus et al. (1991); Subbe et al. (2001))) is not a sufficient mea-
sure of a patient’s true clinical condition, and hence cannot be reliably modeled as an
observable clinical state.
• The same line of argument extends to disease progression models: (Jackson et al.
(2003)) has shown that significant modeling gain can be attained by treating clinical
markers and diagnostic assessments as noisy, potentially erroneous manifest variables
for the patient’s true clinical state rather than defining a clinical state in terms of
those markers.
• For various chronic disease, such as HIV, Scleroderma, and kidney disease, progres-
sion stages are well defined in terms of observable clinical markers (CD4 cell count,
PFVC and GFR). However, a latent variable model can help validate and assess the
current domain knowledge-based clinical practice guidelines by learning alternative,
data-driven guidelines. Other diseases, such as COPD, have their progression stages
manifesting only through symptoms (e.g. chronic bronchitis, emphysema and chronic
airway obstruction (Wang et al. (2014))), which may or may not accurately reflect
the disease’s true state, and hence a latent variable model is necessary.
• Conclusive clinical markers that reveal a patient’s true state may be available only
occasionally in a patient’s longitudinal episodes. For instance, in a breast cancer
progression setting, most of the data points associated with a patient’s longitudinal
episode would be imaging test results (e.g. BI-RADS scores of a mammogram or an
MRI (Gail and Mai (2010); Taghipour et al. (2013))), which are noisy markers for the
existence of a tumor, whereas a conclusive biopsy result that truly reveals whether the
patient is in a preclinical or clinical breast cancer state may not be available because
the patient did not undergo a biopsy test. A latent variable model better suits such
settings.
• A fully observable model does not provide diagnostic utility since it assumes that an
already observable clinical marker provides an immediate, domain-knowledge-based
diagnosis for the patient. Contrarily, a latent variable model leaves room for diagnoses
to be learned from the evidential data by learning the association between physiologi-
cal evidence and clinical states, which may help inform and improve clinical practice.
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1.1.2 Challenges
Hidden Markov Models (HMMs) and their variants have been widely deployed as tem-
poral latent variable models for dynamical systems (Smyth (1994); Zhang et al. (2001);
Giampieri et al. (2005); Genon-Catalot et al. (2000); Ghahramani and Jordan (1997)). Such
models have achieved considerable success in various applications, such as topic model-
ing (Gruber et al. (2007)), speaker diarization (Fox et al. (2011b)), and speech recognition
(Rabiner (1989)). However, the nature of the clinical setting, together with the format of
the modern EHR data pose the following set of serious challenges that confound classical
HMM models:
(A) Non-stationarity: Recently developed disease progression models, such those in
(Wang et al. (2014)) and (Liu et al. (2015)), use conventional stationary Markov chain mod-
els. In particular, they assume that state transition probabilities are independent of time.
However, this assumption is seriously at odds with even casual observational studies which
show that the probability of transiting from the current state to another state depends on the
time spent in the current state (Lagakos et al. (1978); Huzurbazar (2004); Gillaizeau et al.
(2015)). This effect, which violates the memorylessness assumptions adopted by continuous-
time Markovian models, was verified in patients who underwent renal transplantation
(Foucher et al. (2007, 2008)), patients who are HIV infected (Joly and Commenges (1999);
Dessie (2014); Foucher et al. (2005)), and patients with chronic obstructive pulmonary dis-
ease (Bakal et al. (2014); Wang et al. (2014)).
(B) Irregularly spaced observations: The times at which the clinical findings of a
patient (vital signs or lab tests) are observed is controlled either by clinicians (in the case of
hospitalized inpatients), or by the patient’s visit times (in the case of a chronic disease fol-
low up). The time interval between every two measurements may vary from one patient to
another, and may also vary for the same patient within her episode. This is reflected in the
structure of the episodes in the EHR records, as shown in Figure 1 and 2. Figure 1 depicts an
actual diastolic blood pressure episode for a patient hospitalized in a regular ward for 1200
hours (50 days)2. The patient’s stay in the ward was concluded with an admission to the
ICU after the ward staff realized she was clinically deteriorating. As we can see, the blood
pressure measurements in the first 20 hours were initially taken with a rate of 1 sample per
hour, and then later the rate changed to 1 sample every 5 hours3. Thus, a direct application
of a regular, discrete-time HMM (e.g. the models in (Murphy (2002); Fox et al. (2011b,a);
Rabiner (1989); Yu (2010); Matos et al. (2006); Guihenneuc-Jouyaux et al. (2000))) will not
suffice for jointly describing the latent states and observations, and hence ensuring accurate
inferences.
(C) Discrete observations of a continuous-time phenomena: A patient’s physiolog-
ical signals and latent states evolve in continuous time; however, the observed physiological
measurements are gathered at discrete time steps. The intervals between observed measure-
2. A detailed description for the data involved in this paper is provided in Section 5.
3. While Figure 1 illustrates a short-term episode for a critical care patient, similar effects are experienced
in longitudinal episodes for patients with chronic disease (see Figure 4 in (Wang et al. (2014))).
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ments can vary quite significantly; as we can see in Figure 2, the systolic blood pressure for
a patient who stayed in a ward for 140 hours exhibits an entire day without measurements 4.
This means that the patient may encounter multiple hidden state transitions without any
associated observed data. These effects make learning and inference problems more com-
plicated since the inference algorithms need to consider potential unobserved trajectories of
state evolution between every two timestamps. This challenge has been recently addressed
in (Nodelman et al. (2012); Wang et al. (2014); Liu et al. (2015)), but only on the basis
of memoryless Markov chain models for the hidden states, for which tractable inferences
that rely on the solutions to Chapman-Kolmogorov equations can be executed. However,
incorporating non-stationarity in state transitions (i.e. addressing challenge (1) in this list)
would make the problem of reasoning about a continuous-time process through discrete
observations much more complicated.
(D) Lack of supervision: The episodes in the EHR may be labeled with the aid of
domain knowledge (e.g. the stages and symptoms of some chronic diseases, such as chronic
kidney disease (Eddy and Neilson (2006)), are known to clinicians and may be provided in
the EHR). However, in many cases, including the case of (post or pre-operative) critical
care, we do not have access to any labels for the patients’ states. Hence, unsupervised learn-
ing approaches need to be used for learning model parameters from EHR episodes. While
unsupervised learning of discrete-time HMMs has been extensively studied and is well un-
derstood (e.g. the Baum-Welch EM algorithm is predominant in such settings (Zhang et al.
(2001); Yu (2010); Rabiner (1989))), the problem of unsupervised learning of continuous-
time models for which both the patient’s states and state transition times are hidden is far
less understood, and indeed far more complicated.
(E) Censored observations: Episodes in the EHR are usually terminated by an in-
formative intervention or event, such as death, ICU admission, discharge, etc. This is
known as informative censoring (Scharfstein and Robins (2002); Huang and Wolfe (2002);
Link (1989)). Unlike classical HMM settings where training sets comprise fixed length, or
arbitrarily-censored, HMM sequence instances, a typical EHR dataset would comprise a set
of episodes with different durations, and the duration of each episodes is itself informative
of the entire state evolution trajectory. Learning in such settings requires novel algorithms
that can efficiently compute the likelihood of observing a set of episodes conditioned on
their durations and terminating states.
1.2 Summary of Contributions
In order to address the challenges above, we develop a new model –which we call the Hidden
Absorbing Semi-Markov Model (HASMM)– as a versatile generative model for a patient’s
(physiological) episode as recorded in the EHR. The HASMM captures non-stationary tran-
sitions for a patient’s clinical state via a continuous-time semi-Markov model with explicitly
specified state sojourn time distributions. Informative censoring is captured via absorbing
4. This may have resulted due to the patient undergoing a surgery or an intervention, or because the EHR
recording system accidentally did not receive the data from the clinicians during that day.
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states that designate clinical endpoint outcomes (e.g. cardiac arrest, mortality, recovery,
etc); entering an absorbing state of an HASMM stimulates censoring events (e.g. clinical
deterioration leads to an ICU admission which terminates the physiological observations
for a monitored patient in a ward, etc). Observable variables are modeled via a multi-task
Gaussian process (Bonilla et al. (2007)), for which the observation times (i.e. follow up
visits, vital sign gathering, lab tests, etc) are modeled as a point process. Using multi-task
Gaussian process with state-dependent hyper-parameters, an HASMM accounts for both
correlations among different physiological variables, in addition to the temporal correlations
among the observation variables that are generated by the same hidden state during its so-
journ period. In that sense, an HASMM is a segment model (Ostendorf et al. (1996)) and
also a state-switching model (Fox et al. (2011a))).
To allow for real-time inference of a patient’s state, we develop a forward-filtering
HASMM inference algorithm that can estimate a patient’s latent state using her history
of irregularly sampled physiological measurements. The inference algorithm operates by
constructing a virtual, discrete-time embedded Markov chain that fully describes the pa-
tient’s state transitions at observation times. The embedded Markov chain is constructed
in an offline stage by solving a system of Volterra integral equations of the second kind using
the successive approximation method; the solution to this system of equations, which paral-
lels the Chapman-Kolmogorov equations in ordinary Markov chains, describe the HASMM’s
semi-Markovian state transitions as observed at arbitrarily selected discrete timestamps.
Offline learning of the HASMM model parameters from patients’ episodes in an EHR is
a daunting task. Since the HASMM is a continuous-time model, we cannot directly use the
classical Baum-Welch EM algorithms for learning its parameters (Rabiner (1989)). More-
over, the semi-Markovianity of an HASMM yields an intractable integral in the E-step of
the Expectation-Maximization (EM) formulation. Since the HASMM’s state transitions are
not captured by the conventional continuous-time Markov chain transition rate matrices,
we cannot make use of the Expm and Unif methods that were used in (Hobolth and Jensen
(2011)), and more recently in (Liu et al. (2015)) for evaluating the integrals involved in
the E-step of learning continuous-time HMMs. To address this challenge, we develop a
novel forward-filtering backward-sampling Monte Carlo EM (FFBS-MCEM) algorithm that
approximates the integral involved in the E-step by efficiently sampling the latent clinical
trajectories conditioned on observations in the EHR by exploiting the informative censoring
of the patients’ episodes. The FFBS-MCEM algorithm samples the latent clinical states
of every (offline) patient episode in the EHR as follows: it starts from the known clinical
endpoints, and sequentially samples the patient’s states by traversing in the reverse-time
direction while conditioning on the future states, and then uses the sampled state trajecto-
ries to evaluate a Monte Carlo approximation for the E-step.
The rest of the paper is organized as follows. In Section 2, we present the HASMM
model. The HASMM inference algorithm is developed in Section 3, and the learning algo-
rithm is developed in Section 4. In Section 5, we demonstrate the utility of the HASMM
in the problem of critical care prognosis using a real-world dataset for patients admitted to
Ronald Reagan UCLA Medical Center. Conclusions are drawn in Section 6.
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2. The Hidden Absorbing Semi-Markov Model (HASMM)
In this section, we introduce the basic abstract structure of the continuous-time HASMM
(Subsection 2.1), and then we propose the distributional specifications for the model’s vari-
ables (Subsection 2.2).
2.1 Abstract Model
We start by describing the HASMM’s hidden state evolution process, and then we describe
the structure of its observable variables.
2.1.1 Hidden States
We consider a filtered probability space (Ω,F , {Ft}t∈R+ ,P), over which a continuous-time
stochastic process X(t) is defined on t ∈ R+. The process X(t) corresponds to a temporal
trajectory of the patient’s hidden clinical states, which take on values from a finite state-
space X = {1, 2, . . ., N}. Because the process X(t) takes on only finitely many values, it
can be decomposed in the form5
X(t) =
∑
n
Xn · 1{τn≤t<τn+1}, (1)
where (X(t))t∈R+ is a ca`dla`g path (i.e. right-continuous with left limits), and the interval
[τn, τn+1) is the time interval accommodating the n
th hidden state, which takes on a value
Xn ∈ X . Every path (X(t))t∈R+ on the stochastic basis (Ω,F , {Ft}t∈R+ ,P) is a semi-
Markov path (Janssen and De Dominicis (1984); Durrett (2010)), where the sojourn time
of state n, which we denote as Sn = τn+1 − τn, is drawn from a state-specific distribution
vj(Sn = s |λj ) = dP(Sn = s |Xn = j ), with λj being a state-specific duration parameter
associated with state j ∈ X . Unlike ordinary time-homogeneous semi-Markov transitions,
in which the transition probabilities among states are assumed to be constant conditioned
on there being a transition from the current state (Gillaizeau et al. (2015); Murphy (2002);
Johnson and Willsky (2013); Yu (2010); Dewar et al. (2012); Gue´don (2007)), our model
accounts for duration-dependent semi-Markov transitions. In other words, the transition
probability from one state to another depends on the time elapsed in the current state, i.e.
P(Xn+1 = j|Xn = i, Sn = s) = gij(s), (2)
where gij : R+ → [0, 1], ∀i, j ∈ X is a transition function for which
∂gij(s)
∂s
is well defined,
and
∑N
j=1 gij(s) = 1,∀s ∈ R+, i ∈ X .
Now consider the bivariate (renewal) process (Xn, Sn)n∈N+ , which comprises the se-
quence of states and sojourn times. The semi-Markovian nature of X(t) implies that
5. By convention, we set τ1 = 0.
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(Xn, Sn)n∈N+ satisfies the following condition on its transition probabilities
P(Xn+1 = j, Sn ≤ s|Fτ−n ) = P(Xn+1 = j, Sn ≤ s|Xn = i)
= P(Xn+1 = j|Xn = i, Sn ≤ s) · P(Sn ≤ s|Xn = i)
= ESn [gij(Sn)|Sn ≤ s] · Vi(s|λi)
= g¯ij(s) · Vi(s|λi), (3)
where Vi(.) is the cumulative distribution function of state i’s sojourn time, and g¯ij(s)
is the probability mass function that reflects the probability that a patient’s next state
being j given that she was at state i and her sojourn time in i is less than (or equal to)
s. Based on (3), we define the semi-Markov transition kernel as a matrix-valued function
Q : R+ → [0, 1]
N×N that describes the dynamics of X(t) in continuous time, with entries
Q(s) = (Qij(s))i,j∈X that are given by
Qij(s) = g¯ij(s) · Vi(s|λi). (4)
Since the observable episode for a patient can begin in an arbitrary clinical state (because
we only observe the physiological measurements starting from the time when the patients
are hospitalized or start taking clinical tests), then it follows that the initial state X1 is
random6. The initial state distribution is given by
po = [po1, p
o
2, . . ., p
o
N ]
T ,
where poj = P(X(0) = j), and
∑N
j=1 p
o
j = 1.
The hidden states reflect different levels of clinical risk or severity (e.g. progression stage
indexes of a chronic disease or phases of clinical deterioration (Sweeting et al. (2010);Chen and Zhou
(2011))). In that sense, state 1 is regarded as the “least risky state”, and state N is regarded
as the “most risky state”. We define and interpret states 1 and N as follows:
• State 1 is denoted as the safe state, and represents the state at which the patient is
at minimum (or no) risk (e.g. clinically stable post-operative patient, etc).
• State N is denoted as the catastrophic state, and represents the state at which the
patient is at severe risk or encounters an adverse event (e.g. a very severe stage of
a chronic disease (Bakal et al. (2014)), a cardiac or respiratory arrest (Subbe et al.
(2001)), mortality (Knaus et al. (1991)), etc).
We assume that whenever the system enters either state 1 or state N , it remains there
forever7. Therefore, we model states {1, N} as absorbing states, whereas we model the re-
maining states in X \ {1, N} as transient states that represent intermediate levels of risk.
Following the assumptions in (Murphy (2002); Johnson and Willsky (2013)), we eliminate
the self-transitions for all transient states by setting gii(s) = 0, Qii(s) = 0,∀s ∈ R+, i ∈
X \ {1, N}, whereas we restrict the transitions from states 1 and N to self-transitions only,
i.e. gii(s) = 1, i ∈ {1, N}. Figure 3 depict the Markov chain for the sequence {Xn}n∈N+ .
6. We do not consider left-censored observations in this model.
7. The model can be easily extended to accommodate an arbitrary number of competing absorbing states.
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321 4 5
Figure 3: The Markov chain model for a 5-state HASMM.
We define A1 as the event that the path (X(t))t∈R+ is absorbed in the safe state 1,
i.e. A1 = {limt→∞X(t) = 1}, and AN as the event that (X(t))t∈R+ is absorbed in the
catastrophic state N , i.e. AN = {limt→∞X(t) = N}. Since (X(t))t∈R+ is an absorbing
semi-Markov chain8, we know that P(A1 ∨ AN ) = 1, and since the events A1 and AN are
mutually exclusive, it follows that P(AN) = 1 − P(A1). The quantity P(AN ) describes a
patient’s prior risk of ending in the catastrophic state, whereas P(AN |Ft ) describes the
patient’s posterior risk of ending in the catastrophic state having observed its evolution
history up to time t9. Define Ts as an F-stopping time representing the absorption time of
the path (X(t))t∈R+ in either state 1 or state N , i.e.
Ts = inf{t ∈ R+ : X(t) ∈ {1, N}}.
Finally, we define K as the (random) number of state realizations in the sequence {Xn}
K
n=1
up to the stopping time Ts, which has to be concluded by either state 1 or N , e.g. when X =
4, the sequences {1}, {4}, {2, 3, 2, 3, 4}, and {3, 2, 1} are valid, random-length realizations of
{Xn}
K
n=1, and each represents a certain state evolution trajectory for the patient.
2.1.2 Observations and Censoring
The path (X(t))t∈R+ is unobservable; what is observable is a corresponding process (Y (t))t∈R+
on (Ω,F , {Ft}t∈R+ ,P), the values of which are drawn from an observation-space Y, and
whose distributional properties are dependent on the latent states’ path (X(t))t∈R+ . The
observable process (Y (t))t∈R+ can be put in the form
Y (t) =
∑
n
Yn(t) · 1{τn≤t<τn+1}, (5)
8. We assume that the transition functions gi1(s) and giN (s) for any transient state i is non-zero for every
s. Hence, it follows that (X(t))
t∈R+
is an absorbing semi-Markov chain since it has 2 absorbing states,
each of which can be visited starting from any other state (Durrett (2010)).
9. In the clinical applications under consideration, transient states can be ordered by their respective relative
risks of encountering event AN in the subsequent transitions, i.e. in a 5-state chain, it is more likely for
the patient to be absorbed in state 5 in the future when it is in state 4 than when it is in state 3. For
instance, it is more likely for a patient’s chronic obstructive pulmonary disease that is currently assessed
to have a severity degree of GOLD1 (mild severity as defined in the GOLD standard Pedersen et al.
(2011)) to progress (in the near future) to a severity degree of GOLD2 (moderate) rather than GOLD3
(severe).
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where (Y (t))t∈R+ is a ca`dla`g path, comprising a sequence of function-valued variables
{Yn(t)}
K
n=1, with Yn : [τn, τn+1) → Y. Even though the path (Y (t))t∈R+ is accessible,
only a sequence of irregularly spaced samples of it is observed over time, and is denoted by
{Y (tm)}tm∈T , where T = {t1, t2, . . ., tM} is the set of observed measurements, andM is the
total number of such measurements. We say that the process is censored if M <∞; typical
episodes in an EHR are censored: observations stop at some point of time due to a release
from care, an ICU admission, mortality, etc.
The sampling times in T represent the times at which a patient with a chronic dis-
ease took clinical tests (i.e. time intervals in T spans years), or the times at which clin-
icians have gathered vital signs for a monitored critically ill patient in a hospital ward
(i.e. time intervals in T span days or hours). We assume that the sampling times in T
are drawn from a point-process Φ(ζ) =
∑
m∈N+
δtm , which is defined on (Ω,F , {Ft}t∈N,P),
and with δt being the Dirac measure. The point process Φ(ζ) is parametrized by an in-
tensity parameter ζ, but is assumed to be independent of the latent states path10. De-
fine Tn as the set of Mn samples that are gathered during the interval
11 [τn, τn+1), i.e.
Tn = {tm : tm ∈ T , tm ∈ [τn, τn+1)},Mn = |Tn|, and
∑
nMn = M . Since Tn could possibly
be empty (Tn = ∅), some states can have no corresponding observations (i.e. an inpatient
may exhibit a transition to a deteriorating state during the night, even though her blood
pressure were not measured during the night. Recall the illustration in Figure 2).
The paths {Yn(t)}
K
n=1 are assumed to be conditionally independent given the hidden
sequence of states {Xn}
K
n=1, and hence we have that
{Y (tm)}tm∈Tn ⊥⊥ {Y (tm)}tm∈Tn+1 |Xn,Xn+1 ,∀n ∈ {1, 2, . . .,K − 1}.
The observed samples generated under every state Xn and sampled at the times in Tn
are drawn from Y according to a distribution P({Y (tm)}tm∈Tn |Xn = j,Θj ), where Θj is an
emission parameter that controls the distributional properties of the observations generated
under state j.
The number of observation samples is finite: the observed sequence is censored at some
point of time, which we call the censoring time Tc, after which no more observation samples
are available. Censoring reflects an external intervention/event that terminated the observa-
tion sequence, i.e. death, intensive care unit (ICU) admission, etc. Censoring is informative
(Scharfstein and Robins (2002);Huang and Wolfe (2002);Link (1989)), because the censor-
ing time is correlated with the absorption time Ts, and Ts strictly precedes Tc (in an almost
sure sense). That is, Tc is an F-stopping time that is given by Tc = Ts + SK , i.e. once the
patient enters state 1 or state N , the observations stop after the patient’s sojourn time in
10. This means that the sampling times are uninformative of the latent states, which makes the inference
problem more challenging. The HASMM model can be easily extended to incorporate a state-dependent
sampling process using a Cox process (Lando (1998)) or a Hawkes process (Hawkes and Oakes (1974))
to modulate the intensity parameter ζ. A good discussion on conditional intensity models can be found
in (Qin and Shelton (2015)).
11. Note that what is observed is a sequence of sampling times T , the elements of which are not labeled by
the corresponding state indexes, for that the states are latent, i.e. the sets Tn are latent.
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that state (i.e. observations stop after a time SK from the entrance in the absorbing state).
Therefore, the duration distributions v1(s|λ1) and vN (s|λN ) of states 1 and N are used to
determine the censoring times conditioned on the chain {Xn}
K
n=1 being absorbed at time Ts.
Every sample from the HASMM is an episode comprising a random-length sequence of
hidden states {Xn}
K
n=1, and a random-length sequence of observations {Y (tm)}
M
m=1 together
with the associated observation times. We only observe {Y (tm)}
M
m=1; the path of latent
statesX(t), the number of realized statesK, the association between observations and states
(i.e. the sets Tn) are all unobserved, which makes the inference problem very challenging,
but captures the realistic EHR data format and the associated inferential hurdles. In the
next subsection, we specify the model’s generative process and present an algorithm to
generate episodic samples from an HASMM.
2.2 Model Specification and Generative Process
As have been discussed in Subsection 2.1, the hidden and observables variables of an
HASMM can be listed as follows:
• Hidden variables: The hidden states sequence {Xn}
K
n=1 and the states’ sojourn
times {Sn}
K
n=1 (or equivalently, the transition times {τn}
K
n=1).
• Observable variables: The observed episode {Y (tm)}
M
m=1 and the associated sam-
pling times T = {tm}
M
m=1.
The HASMM model parameters that generate both the hidden and observable variables are
encompassed in the parameter set Γ, i.e.
Γ =

 N︸︷︷︸
State cardinality
, λ = {λj}
N
j=1︸ ︷︷ ︸
State duration
, po︸︷︷︸
Initial states
,Q = {Qij(s)}
N
i,j=1︸ ︷︷ ︸
Transitions
,Θ = {Θj}
N
j=1︸ ︷︷ ︸
Emission
, ζ︸︷︷︸
Sampling

 .
Since the point process Φ(ζ) does not reveal any information about the latent states, and
hence plays no role in inference, we will drop it from the parameter set Γ in the rest of the
paper. In the following, we specify the distributional properties for both the hidden and
observable variables.
2.2.1 Distributional specifications for the hidden variables
We model the state sojourn time of each state i ∈ X via a Gamma distribution. The se-
lection of a Gamma distribution ensures that the generative process encompasses ordinary
continuous-time Markov models for the path (X(t))t∈R+ , since the exponential distribu-
tion12 is a special case of the Gamma distribution (Durrett (2010)). Thus, if the underlying
physiology of the patient is naturally characterized by memoryless state transitions, this
will be automatically learned from the data via the parameters of the Gamma distribution.
The sojourn time distribution for state i is given by
vi(s|λi = {λi,s, λi,r}) =
1
Γ(λi,s)
· λ
λi,s
i,r · s
λi,s · e−s·λi,r , s ≥ 0,
12. Note that a semi-Markov chain reduces to a Markov chain if the sojourn times are exponentially dis-
tributed.
12
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where λi,s > 0 and λi,r > 0 are the shape and rate parameters of the Gamma distribution
respectively.
Now we specify the structure of the transition kernel Q(s) = (Qij(s))i,j , i, j ∈ X . Re-
call from (4) that the each element in the transition kernel matrix can be written as
ES [gij(S)|S ≤ s] · Vi(s|λi). Having specified the distribution vi(s|λi) as a Gamma distribu-
tion, it remains to specify the function gij(s) in order to construct the elements of Q(s).
The transition functions (gij(s))i,j are given by multinomial logistic functions as follows
gij(s) =
e(ηij+βij ·s)∑N
k=1 e
(ηik+βik·s)
,∀i 6= j, i /∈ {1, N}
gii(s) = 0,∀i ∈ {2, . . . , N − 1},
gii(s) = 1,∀i ∈ {1, N}, (6)
where ηij , βij ∈ R+. The parameters (ηij)
N
j=1 determine the baseline values for the transi-
tion probability mass from state i to state j, i.e. gij(0), whereas the parameters βij controls
the dependence of the transition probability mass on the sojourn time13. If βij = 0, then
we have that gij(s) = gij(0) =
e
ηij
∑N
k=1 e
ηik
,∀s ∈ R+, i.e. the transition probability out of
state i remains constant irrespective of the sojourn time in that state. In the limit when s
13. Similar effects for the sojourn time on the transition probabilities has been demonstrated in the pro-
gression of breast cancer from healthy to preclinical states in (Taghipour et al. (2013)), where age (the
main risk factor for breast cancer) was shown to affect the probability of progressing across the states
of healthy to preclinical, clinical and death. These effects may be also prevailing in other diseases,
or in critical care settings where the length of time during which a patient stays clinically stable may
imply that the patient is more likely to transit to a more healthy state in the future. Through the
HASMM model, we can recognize whether or not this effect is evident in the EHR data, i.e. whether
the transition function reflects an underlying homogeneous (if gij(s) is independent of s) or duration-
dependent transitions by learning the parameter βij . Moreover, the parameter βij is defined per state;
the HASMM model can capture scenarios where transitions are duration-independent from some states,
but are duration-dependent from others.
13
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Figure 6: A basic graphical model for the HASMM.
goes to infinity, the parameter βij dominates the functional form in (6). Figure 4 depicts
exemplary transition functions (gij(s))i,j for a 4-state HASMM.
2.2.2 Distributional specifications for the observable variables
As explained in Subsection 2.1, the observable process Y (t) can be decomposed as Y (t) =∑K
n=1 Yn(t) · 1{τn≤t<τn+1}, where the paths (Yn(t))
K
n=1 are conditionally independent given
the state sequence {Xn}
K
n=1. Since observations are drawn from Y (t) at arbitrarily, and
irregularly spaced time instances T , we have to model the distributional properties of Y (t)
in continuous time. We model every path Yn(t) defined over [τn, τn+1) as a segment drawn
from a multi-task Gaussian Process (GP), with a hyper-parameter set Θi that depends
on the corresponding latent state Xn = i (Rasmussen (2006); Bonilla et al. (2007)). The
input to the multi-task GP is the time variable and the output is the set of physiologi-
cal variables at a certain point of time. The GP associated with every state Xn = i is
parametrized by a constant mean functionmi(t) = mi, a squared-exponential covariance ker-
nel ki(t, t
′
) = σ2i e
− 1
2ℓ2
i
||t−t
′
||2
, and a “free-form” covariance matrix Σi between the different
physiological measurements (Bonilla et al. (2007)). Thus, for a Q-dimensional physiological
stream Y (t) = (Y 1(t), . . ., Y Q(t)), the observations for state i are generated as follows〈
Y li (t) · Y
v
i (t
′
)
〉
= Σi(l, v) · ki(t, t
′
) {Y li (t)}t∈T ,1≤l≤Q ∼ N (mi(t),Σi),
where Σi(l, v, t, t
′
) =
〈
Y li (t) · Y
v
i (t
′
)
〉
. The GP hyper-parameters associated with state i
are given by Θi = (mi, σi,Σi, ℓi), i.e. Yn(t)|Xn = i ∼ GP(Θi).
We note that the HASMM model is a segment model (Ostendorf et al. (1996); Murphy
(2002); Yu (2010); Gue´don (2007)), i.e. observation samples that are defined within the
sojourn time of the same state are correlated, but observation samples in different states
are independent. The model can also be viewed as a state-switching model, but for which
14
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the transition dynamics do not need to be linear as in (Georgatzis et al. (2016); Fox et al.
(2011a)), but rather depend on the covariance kernel ki(t, t
′
). Figure 5 depicts the corre-
lation structure of the observable variables in terms of the covariance matrix of a discrete
version of Y (t) generated under a specific hidden state sequence. We can see that con-
ditioned on the hidden state sequence, the covariance matrix is a block diagonal matrix,
where the sizes of the blocks are random and are determined by the hidden states’ sojourn
times.
The sampling times in T are generated by the point process Φ(ζ), which for the sake
of completeness of the model description, we specify as a Poisson process with an intensity
parameter ζ. Note though that since we assume the sampling times are uninformative of the
latent states path X(t), the distributional specification of Φ(ζ) is ancillary to the inference
and learning algorithms developed in Sections 3 and 4.
2.2.3 Sampling episodes from an HASMM
We conclude this Section by presenting an algorithm for sampling episodes from an HASMM
with a hyper-parameter set Γ. Algorithm 1 (GenerateHASMM(Γ))14 samples a patient’s
episodes by first sampling an initial state from X , and then sequentially samples sojourn
times s from the Gamma distribution, and new states using the semi-Makrov kernel Q(s),
until an absorbing state is drawn. Figure 7 depicts an episode sampled via Algorithm 1.
3. Inference in Hidden Absorbing Semi-Markov Models
In this Section, we develop an online algorithm that carries out diagnostic and prognostic
inferences for a monitored patient’s episode in real-time. Given an ongoing realization
of an episode {y(t1), y(t2), . . ., y(tm)} at time tm (before the censoring time Tc), and the
14. Our HASMM toolbox for Matlab is available at https://github.com/ahmedmalaa/HASMMtoolbox.
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Algorithm 1 Sampling episodes from an HASMM
1: procedure GenerateHASMM(Γ)
2: Input: HASMM model parameters Γ = (N,λ,po,Q(s),Θ, ζ)
3: Output: An episode ({Xn}
K
n=1, {τn}
K
n=1, {Y (tm)}
M
m=1, {tm}
M
m=1)
4: τ1 ← 0, k ← 1, T ∼ Poisson(ζ) ⊲ Initializations
5: x1 ∼ Multinomial(p
o
1, p
o
2, . . ., p
o
N ) ⊲ Sample an initial latent state
6: s1 ∼ Gamma(λx1,s, λx1,r), τ2 ← τ1 + s1
7: T1 = {t ∈ T : τ1 ≤ t ≤ τ2}
8: while xk /∈ {1, N} do ⊲ Sample latent states until absorption
9: xk+1 ∼ Multinomial(gxk1(sk), gxk2(sk), . . ., gxkN (sk))
10: sk+1 ∼ Gamma
(
λxk+1,s, λxk+1,r
)
, τk+2 ← τk+1 + sk+1
11: Tk+1 = {t ∈ T : τk+1 ≤ t ≤ τk+2}
12: {y(tm)}tm∈Tk+1 ∼ GP(Θxk+1) ⊲ Sample observations from a Gaussian Process
13: k ← k + 1
14: end while
15: return ({xn}
K
n=1, {τn}
K
n=1, {y(tm)}
M
m=1, {tm}
M
m=1)
16: end procedure
HASMMmodel parameter Γ that has generated this realization (i.e. {y(t1), y(t2), . . ., y(tm)}
is sampled via the algorithm GenerateHASMM(Γ)), we aim at carrying out the following
inference tasks:
• Diagnosis: Infer the patient’s current clinical state, i.e. compute
P(X(tm) = j |Y (t1) = y(t1), . . ., Y (tm) = y(tm),Γ), ∀j ∈ X .
• Prognostic Risk Scoring: Compute the patient’s risk of absorption in the catas-
trophic state, i.e.
P(AN |Y (t1) = y(t1), . . ., Y (tm) = y(tm),Γ).
In the rest of this Section, we drop the conditioning on Γ for notational brevity. The
first inference task corresponds to disease severity estimation for patients with chronic
disease, or clinical acuity assessment for critical care patients. The second task corresponds
to risk scoring for future adverse events for patients who have been monitored for some
period of time, i.e. the risk of developing a future preclinical or clinical breast cancer state
(Gail and Mai (2010)), the risk of clinical deterioration for post-operative patients in wards
(Rothman et al. (2013)), the risk of mortality for ICU patients (Knaus et al. (1985)), etc.
3.1 Challenges facing the HASMM Inference Tasks
The inference tasks discussed in the previous Subsection are confronted with 3 main chal-
lenges –listed hereunder– that hinder the direct deployment of classical forward-backward
message-passing routines.
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Figure 8: An exemplary HASMM episode with 6 hidden state realizations and 9 observed samples.
1. In addition to the clinical states {Xn}
K
n=1 being unobserved, the transition times
among the states, {τn}
K
n=1, are also unobserved (i.e. we do not know the time at
which the patient’s state changed). Thus, unlike the discrete-time models in (Murphy
(2002); Johnson and Willsky (2013); Yu (2010); Dewar et al. (2012); Gue´don (2007)),
in which we know that the underlying states switch sequentially in a (known) one-
to-one correspondence with the observations, in an HASMM the association between
states and observations is unknown. Figure 8 depicts an exemplary HASMM episode
with 6 realized states and 9 observations samples; in this realization, the association
between the observations {Y (t1), Y (t2), Y (t3)} and state X1 is hidden. The impor-
tance of reasoning about the hidden transition times is magnified by the duration-
dependence of the transition probabilities that govern the sequence {Xn}
K
n=1.
2. Since observations are made at random and arbitrary time instances, some transitions
may not be associated with any evidential data. That is, as it is the case for state X2 in
Figure 8, there is no guarantee that for every state Xn, an observation is drawn during
its occupancy, i.e. [τn, τn+1). In a practical setting, the inference algorithm should
be able to reason about the state trajectories even in silence periods that come with
no observations (recall the example in Figure 2 where observations of a critical care
patient’s systolic blood pressure stop for an entire day). Hence, one cannot directly
discretize the time variable and use the discrete-time HMM inference algorithms (e.g.
the algorithms in (Rabiner (1989))) since in that case we would exhibit time steps
that come with no associated observations, and with potential state transitions.
3. The HASMM model assumes that observations that belong to the same state are
correlated (e.g. in Figure 8, each of the subset of observations {Y (t1), Y (t2), Y (t3)},
{Y (t4), Y (t5)} and {Y (t7), Y (t8)} are not drawn independently conditioned on the la-
tent state since they are sampled from a GP), thus we cannot use the variable-duration
and explicit-duration HSMM inference algorithms in (Murphy (2002); Johnson and Willsky
(2013); Yu (2010); Gue´don (2007)), as those assume that all observations are condi-
tionally independent given the latent states. Our model is closer to a segment-HSMM
model (Yu (2010); Gue´don (2007)), but with irregularly spaced observations and an
underlying duration-dependent state evolution process, which requires a different con-
struction of the forward messages.
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In the following Subsection, we develop a forward filtering algorithm that deal with episodes
generated from an HASMM and address the above challenges.
3.2 The HASMM Forward Filtering Algorithm
Given a realization of an episode {y(t1), y(t2), . . ., y(tm)} at time tm, the posterior proba-
bility of the patient’s current clinical state X(tm) is given by
15
P(X(tm) = j | y(t1), . . ., y(tm),T ) =
dP(X(tm) = j, y(t1), . . ., y(tm) | T )
dP(y(t1), . . ., y(tm)|T )
=
dP(X(tm) = j, y(t1), . . ., y(tm) | T )∑N
j=1 dP(X(tm) = j, y(t1), . . ., y(tm) | T )
. (7)
The above application of Bayes’ rule implies that, given the observation times T , com-
puting the joint probability density dP(X(tm) = j, y(t1), . . ., y(tm) | T ) suffices for com-
puting the posterior probability of the patient’s clinical states. As it is the case for the
conventional HMM setting, we denote these joint probabilities as the forward messages
αm(j | T ) = dP(X(tm) = j, y(t1), . . ., y(tm) | T ).
Since the HASMM is a segment model, the conventional notion of the forward messages
αm(j | T ) does not suffice for constructing the forward filtering algorithm since we need to
account for the latent correlation structures between the (conditionally-dependent) obser-
vations (Murphy (2002)). To that end, we define αm(j, w | T ) as the forward message for
the jth state at the mth observation time (i.e. tm) with a lag w as follows
αm(j, w | T ) = dP(X(tm) = j, {tu}
m
u=m−w+1 ∈ Tn, tm−w ∈ Tn′ , {y(tu)}
m
u=1 | T ), (8)
for some n, n
′
∈ N+, and n 6= n
′
. That is, the forward message αm(j, w | T ) is sim-
ply the joint probability that the current state is j, that the associated observations are
(y(t1), . . ., y(tm)), and that the current state has lasted for the last w measurements. For
notational brevity, denote the event
{
{tu}
m
u=m−w+1 ∈ Tn, tm−w ∈ Tn′
}
as ψ(m,w). Thus,
αm(j, w | T ) can be written as
αm(j, w | T ) =
N∑
i=1
m−w∑
w
′=1
dP(X(tm) = j, ψ(m,w),X(tm−w) = i, ψ(m − w,w
′
), {y(tu)}
m
u=1 | T ),
which can be decomposed using the conditional independence properties of the states, ob-
servable variables and sojourn times as follows
dP(X(tm) = j, ψ(m,w),X(tm−w) = i, ψ(m − w,w
′
), {y(tu)}
m
u=1) =
dP({y(tu)}
m
u=m−w+1 |X(tm) = j, ψ(m,w)) × P(X(tm) = j |X(tm−w) = i, ψ(m − w,w
′
))︸ ︷︷ ︸
pij(tm−tm−w ,ψ(m−w,w
′))
×
P(ψ(m,w) |X(tm) = j)︸ ︷︷ ︸
Vj(tm−tm−w|λj)−Vj(tm−tm−w+1|λj)
× dP(X(tm−w) = i, ψ(m − w,w
′
), {y(tu)}
m−w
u=1 )︸ ︷︷ ︸
αm−w(i,w
′)
, (9)
15. We use the notation dP to denote a probability density defined with respect to (Ω,F , P).
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where we have dropped the conditioning on T for notational brevity. The first term,
dP({y(tu)}
m
u=m−w+1 |X(tm) = j, ψ(m,w)), is the probability density of the observable vari-
ables in {y(tu)}
m
u=m−w+1 conditioned on the hidden state being X(tm) = j and that the
time instances {tu}
m
u=m−w+1 reside in the sojourn time of X(tm) = j. The second term,
pij(tm − tm−w, ψ(m − w,w
′
)), is the interval transition probability, i.e. the probability
that the hidden state sequence transits to state j after a period of tm − tm−w, given that
its sojourn time in state X(tm−w) = i at time tm is at least tm − tm−w+1, and at most
tm− tm−w−w′ . The third term is the probability that the sojourn time in state X(tm) = j is
between tm−tm−w+1 and tm−tm−w, whereas the fourth term, αm−w(i, w
′
), is the (m−w)th
forward message with a lag of w
′
. Thus, we can write the mth forward message with a lag
w as follows
αm(j, w) = dP({y(tu)}
m
u=m−w+1 |X(tm) = j)×
N∑
i=1
m−w∑
w
′=1
pij(tm − tm−w, ψ(m− w,w
′
)) · (Vj(tm − tm−w|λj)− Vj(tm − tm−w+1|λj)) · αm−w(i, w
′
).
(10)
As we can see in (10), one can express αm(j, w) using a recursive formula that makes use of
the older forward messages {αm−w(i, w
′
)}mw=1, where αo(i, w
′
) = 0, which allows for an effi-
cient dynamic programming algorithm to infer the patient’s clinical state in real-time; this
is important in critical care settings where prompt risk assessments are crucial for timely
clinical intervention.
The construction of the forward messages in (10) parallels the structure of forward
message-passing in segment-HSMM (See Section 1.2 in (Murphy (2002)) and Section 4.2.2
in (Yu (2010))), but with the following differences. In (10), the time interval between every
two observation samples is irregular, which reflects in the correlation between the observa-
tions in {y(tu)}
m
u=m−w+1 (depends on the covariance kernel of the GP, and the probability
of the current latent state’s sojourn time being encompassing the most recent w samples,
i.e. (Vj(tm − tm−w|λj)− Vj(tm − tm−w+1|λj)). However, the most challenging ingredient of
the forward message is the interval transition probability pij(tm−tm−w, ψ(m−w,w
′
)). This
is because unlike the discrete-time HSMM models in (Murphy (2002); Yu (2010)), which
exhibit transitions only at discrete time steps that are always accompanied with evidential
observations, i.e. no hidden transitions can occur between observation samples, and the
transitions among hidden states are duration-independent, in an HASMM, transitions can
occur at arbitrary time instances, multiple transitions can occur between two observation
samples, and transitions are duration-dependent.
In order to evaluate the term pij(tm − tm−w, ψ(m − w,w
′
)), we construct a virtual
(discrete-time) trivariate embedded Markov chain {X(tm), tm−w, tm−w+1}, the transition
probabilities of which are equal to the interval transition probabilities. In the recent work
in (Liu et al. (2015)), a similar embedded Markov chain analysis was conducted for a CT-
HMM, but for which the underlying state evolution process was assumed to be a duration-
independent ordinary Markov chain for which the expressions for the interval transition
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probabilities are readily available by virtue of the exponential distributions of the memory-
less state sojourn times.
Recall from Subsection 2.1.1 that the semi-Markov kernel of the hidden state sequence
{Xn}
K
n=1 is defined as Qij(τ) = P(Xn+1 = j, Sn ≤ τ |Xn = i), i.e. the probability that
the sequence transits from state i to state j given that the sojourn time in i is less than
or equal to τ . Theorem 1 establishes the methodology for computing the interval tran-
sition probabilities pij(tm − tm−w, ψ(m − w,w
′
)) using the parameters of an HASMM.
In Theorem 1, we define P˜(τ,
¯
s, s¯) as a matrix-valued function P˜ : S → [0, 1]N×N , S =
{(τ,
¯
s, s¯) : τ ∈ R+, s¯ ∈ R+,
¯
s ≤ s¯} , the entries of which are given by
P˜(τ,
¯
s, s¯) =


p˜11(τ,
¯
s, s¯) p˜21(τ,
¯
s, s¯) · · · p˜N1(τ,
¯
s, s¯)
p˜12(τ,
¯
s, s¯) p˜22(τ,
¯
s, s¯) · · · p˜N2(τ,
¯
s, s¯)
...
...
...
p˜1N (τ,
¯
s, s¯) p˜2N (τ,
¯
s, s¯) · · · p˜NN (τ,
¯
s, s¯)


︸ ︷︷ ︸
SizeN×Nmatrix
.
In addition, we define a truncated semi-Markov kernel as
Q¯ij(τ,
¯
s, s¯) =
∫ s¯
s=
¯
s
(g¯ij(τ + s)− g¯ij(s)) ·
Vi(τ + s|λi)− Vi(s|λi)
1− Vi(s|λi)
· dVi(s|λi),
a scalar-valued function Q¯i(τ,
¯
s, s¯) =
∑
j∈X\{i} Q¯ij(τ,¯
s, s¯), and a matrix-valued function
Q¯(τ,
¯
s, s¯) =


0 Q¯21(τ,
¯
s, s¯) · · · Q¯N1(τ,
¯
s, s¯)
Q¯12(τ,
¯
s, s¯) 0 · · · Q¯N2(τ,
¯
s, s¯)
...
...
...
Q¯1N (τ,
¯
s, s¯) Q¯2N (τ,
¯
s, s¯) · · · 0


︸ ︷︷ ︸
SizeN×Nmatrix
.
Theorem 1 (Interval transition probabilities) Let P˜(τ,
¯
s, s¯) be the solution to the fol-
lowing integral equation
P˜(τ,
¯
s, s¯) = IN×N −diag
(
Q¯1(τ,
¯
s, s¯), . . . , Q¯N (τ,
¯
s, s¯)
)
+
∫ τ
u=0
∂Q¯(u,
¯
s, s¯)
∂u
× P˜(τ −u, 0, 0) du,
(11)
for the three independent variables (τ,
¯
s, s¯) ∈ S. Then, the interval transition probability pij
is given by
pij(tm − tm−w, ψ(m− w,w
′
)) = p˜ij(τ,
¯
s, s¯),∀i, j ∈ X ,
at τ = tm − tm−w,
¯
s = tm − tm−w+1, and s¯ = tm − tm−w+w′ .
Proof See Appendix A.
Theorem 1 follows from a first-step analysis that is akin to the derivation of the conven-
tional Chapman-Kolmogorov equations in ordinary Markov chains (Kulkarni (1996)). The
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integral equation in (11) is a (matrix-valued) non-homogeneous Volterra integral equation
of the second kind (Polyanin and Manzhirov (2008)).
It can be easily demonstrated that a closed-form solution that hinges on conventional kernel
methods cannot be obtained. Hence, we resort to a numerical method in order to solve (11)
for P˜(τ,
¯
s, s¯), ∀(τ,
¯
s, s¯) ∈ S. Before presenting the numerical method, we reformulate (11)
as follows
P˜(τ,
¯
s, s¯) = IN×N − diag
(
Q¯1(τ,
¯
s, s¯), . . . , Q¯N (τ,
¯
s, s¯)
)
+
(
∂Q¯(.,
¯
s, s¯)
∂u
⋆ P˜(., 0, 0)
)
(τ), (12)
where ⋆ is an element-wise convolution operator. (12) follows from (11) by the fact that
the integral in (11) is a convolution integral; (12) can be expressed as follows
P˜(τ,
¯
s, s¯) = B{Q¯(τ,
¯
s, s¯)}(P˜(τ,
¯
s, s¯)), (13)
where the (functional) operator B{Q}(P˜) is given by
B{Q¯(τ,
¯
s, s¯)}(P˜(τ,
¯
s, s¯)) =
IN×N − diag
(
Q¯1(τ,
¯
s, s¯), . . . , Q¯N (τ,
¯
s, s¯)
)
+F−1
{
F
{
∂Q¯(τ,
¯
s, s¯)
∂τ
}
· F
{
P˜(τ, 0, 0)
}}
,
(14)
where F is the Fourier transform operator, and the transforms in (14) are all taken with
respect to τ .
The solution to (13) can be obtained via the successive approximation method (Opial
(1967)) as follows. We initialize the function P˜(τ,
¯
s, s¯) with the truncated semi-Markov
kernel16 Q¯(τ,
¯
s, s¯), and then iteratively apply the operator B(.) to obtain a new value for
P˜(τ,
¯
s, s¯) until convergence. That is, the successive approximation procedure goes as follows
P˜
o
(τ,
¯
s, s¯) = Q¯(τ,
¯
s, s¯)
While
∥∥∥ P˜z(τ,
¯
s, s¯)− P˜
z−1
(τ,
¯
s, s¯)
∥∥∥
∞
> ǫ
P˜
z
(τ,
¯
s, s¯) = B{Q¯(τ,
¯
s, s¯)}(P˜
z−1
(τ,
¯
s, s¯)).
(15)
The following Theorem establishes the validity of the procedure in (15) as a solver for (13).
Before presenting the statement of Theorem 2, we define the function space P as follows
P =

P˜(τ,¯s, s¯) : p˜ij(τ,¯s, s¯) ∈ [0, 1],∑
j
p˜ij(τ,
¯
s, s¯) = 1, p˜ij(0,
¯
s, s¯) = δij , (τ,
¯
s, s¯) ∈ S

 ,
where δij is the Kronecker delta function.
16. This is a reasonable initialization since the entries of the semi-Markov kernel correspond to interval
transition probabilities conditioned on there being no intermediate transitions on the way from state i
to state j.
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Theorem 2 (Convergence of successive approximations) The functional B{Q¯}(P˜)
has a unique fixed-point P˜
∗
in P, and the successive approximation procedure in (15) always
converges to the fixed point, i.e. P˜
∞
(τ,
¯
s, s¯) = P˜
∗
(τ,
¯
s, s¯), starting from any initial value
P˜
o
(τ,
¯
s, s¯) ∈ P.
Proof See Appendix B.
It is important to note that we do not need to solve for P˜(τ,
¯
s, s¯) during real-time infer-
ence. Instead, we create a look-up table comprising a discretized version of P˜(τ,
¯
s, s¯) =
[p˜ij(a∆τ, b∆
¯
s, c∆s¯))]
i,j,a,b,c
, and then we query this table when performing real-time in-
ference for monitored patients. Hence, efficient and fast inferences can be provided for
critical care patients for whom prompt diagnoses are necessary for the efficacy of clinical
interventions. Algorithm 2 shows a pseudocode for constructing a look-up table of interval
transition probabilities, TransitionLookUp(Γ, ǫ), which takes as an input the parameter
set Γ and a precision level ǫ (to control the termination of the successive approximation
iterations), and outputs the interval transitions look-up table P˜(τ,
¯
s, s¯). In Algorithm 2,
FFT and IFFT refer to the fast Fourier transform operation and its inverse, respectively,
and “diff(.)” refers to a numerical differentiation operation.
Now that we have constructed the algorithm TransitionLookUp to compute the interval
transition probabilities in the look-up table P˜(a∆τ, b∆
¯
s, c∆s¯), we can implement a forward-
filtering inference algorithm using dynamic programming (by virtue of the recursive formula
in (10)). In particular, the posterior probability of the patient’s current clinical state in
terms of the forward messages can be written as
P(X(tm) = j | y(t1), . . ., y(tm) ) =
∑m
w=1 αm(j, w)∑N
k=1
∑m
w=1 αm(k,w)
. (16)
Algorithm 3, ForwardFilter, implements real-time inference of a patient’s clinical state
given a sequence of measurements {y(t1), . . ., y(tm)}. In Algorithm 3, we invoke TransitionLookUp
initially to construct the look-up table of transition probabilities, but in practice, the look-
up table can be constructed in an offline stage once the HASMM parameter set Γ is known.
The number of computations can be reduced by limiting the lags w for every forward
message αm(j, w) to the samples in T that reside in a period tm − Tmax, where Tmax is
derived from the Gamma distribution of the sojourn time (e.g. Tmax can be selected such
that Vi(Tmax|λi) = 90%). The complexity of ForwardFilter is similar to the conventional
forward algorithms in (Rabiner (1989)), i.e. O(Nm2).
3.3 Prognostic risk scoring using an HASMM
Diagnostic inference, e.g. estimating the patient’s current state after a screening test, can
be conducted by a direct application of the forward filtering algorithm presented in the
previous Subsection. In this Subsection, we now explain how prognostic inferences can
also be conducted using the algorithms presented in the previous Subsection. Prognostic
risk scoring plays an important role in designing screening guidelines (Gail and Mai (2010)),
acute care interventions (Knaus et al. (1985)) and surgical decisions (Foucher et al. (2007)).
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Algorithm 2 Constructing a look-up table of interval transition probabilities
1: procedure TransitionLookUp(Γ, ǫ)
2: Input: HASMM parameters Γ and precision ǫ
3: Output: A look-up table [ p˜ij(a∆τ, b∆
¯
s, c∆s¯) ]
i,j,a,b,c
4: Set the values of A,B and C (number of steps), ∆τ (step sizes)
5: for a = 1 to A, b = 1 to B, c = 1 to C do
6: gτij(a∆τ)←
∑a
x=1
e
(ηij+βijx∆τ)
∑N
k=1 e
(ηik+βikx∆τ)
(
1
Γ(λi,s)λ
λi,s
i,r
(x∆τ)λi,s−1 e
−x∆τ
λi,r
)
∆τ
7: gsij(a∆s)←
∑a
x=1
e
(ηij+βijx∆s)
∑N
k=1 e
(ηik+βikx∆s)
(
1
Γ(λi,s)λ
λi,s
i,r
(x∆s)λi,s−1 e
−x∆s
λi,r
)
∆s
8: Q¯ij(a∆τ, b∆
¯
s, c∆s¯)←
∑c
x=b
(gτij(a∆τ)−g
s
ij (x∆s)) (Vi(a∆τ |λi)−Vi(x∆s|λi))
1−Vi(x∆s|λi)
vi(x∆s|λi)
9: end for
10: e = ǫ+ 1
11: z ← 1
12: p˜
(o)
ij (a∆τ, b∆¯
s, c∆s¯)← Q¯ij(a∆τ, b∆
¯
s, c∆s¯), ∀a, b, c, i, j.
13: while e > ǫ do
14: CQi,j,k(a∆τ, b∆
¯
s, c∆s¯)←
15: IFFT
(
FFT
(
diff
(
Q¯ik(a∆τ, b∆
¯
s, c∆s¯)
))
,FFT
(
p˜
(z−1)
jk (a∆τ, b∆¯
s, c∆s¯)
))
,
16: p˜
(z)
ij (a∆τ, b∆¯
s, c∆s¯)← δij Q¯ij(a∆τ, b∆
¯
s, c∆s¯) +
∑N
k=1CQi,j,k(a∆τ, b∆¯
s, c∆s¯)
17: P˜
(z)
(a∆τ, b∆
¯
s, c∆s¯) =
[
p˜
(z)
ij (a∆τ, b∆¯
s, c∆s¯))
]
i,j,a,b,c
18: e←
∥∥∥ P˜(z)(a∆τ, b∆
¯
s, c∆s¯)− P˜
(z−1)
(a∆τ, b∆
¯
s, c∆s¯)
∥∥∥
∞
19: z ← z + 1
20: end while
21: return P˜
(z)
(a∆τ, b∆
¯
s, c∆s¯)
22: end procedure
A risk score is a measure for the patient’s risk of encountering an adverse event (abstracted
as state N in our model) at any future time step starting from time tm. That is, the
patient’s risk score at time tm can be formulated as
R(tm) = P(AN | {y(tu)}
m
u=1,Γ)
= 1− P(X(∞) = N | {y(tu)}
m
u=1,Γ), (17)
which can be computed using the outputs of TransitionLookUp and ForwardFilter as
follows
R(tm) =
N∑
j=1
p˜jN(A, 0, 0) ·
∑m
w=1 αm(j, w)∑N
k=1
∑m
w=1 αm(k,w)
. (18)
Therefore, the procedures TransitionLookUp and ForwardFilter suffice for executing both
the diagnostic and prognostic inference tasks.
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Algorithm 3 Forward filtering inference
1: procedure ForwardFilter(Γ, {y(tw)}
m
w=1, ǫ)
2: Input: Observed samples {y(tw)}
m
w=1, HASMM parameters Γ, and precision ǫ
3: Output: The posterior state distribution {P(X(tm) = j | {y(tw)}
m
w=1)}
N
j=1
4: P˜(a∆τ, b∆
¯
s, c∆s¯)← TransitionLookUp(Γ, ǫ)
5: α1(j, 1) = dP(y(t1) |X(t1) = j)
∑N
i=1 p˜ij(t1, 0, 0) · p
o
i , ∀j ∈ X
6: for z = 2 to m do
7: for w = 1 to z do
8: a∗(z, w) = argmina |tz − tz−w − a∆τ |
9: b∗(z, w) = argminb |tz − tz−w+1 − b∆
¯
s|
10: c∗(z, w,w
′
) = argminc
∣∣tz − tz−w−w′ − c∆s¯∣∣
11: αz(j, w) = dP({y(tu)}
z
u=z−w+1 |X(tz) = j)
∑N
i=1
∑z−w
w
′=1
αz−w(i, w
′
)×
p˜ij(a
∗(z, w)∆τ, b∗(z, w)∆
¯
s, c∗(z, w,w
′
)∆s¯) × (Vj(tz − tz−w|λj)− Vj(tz − tz−w+1|λj))
12: end for
13: end for
14: P(X(tm) = j | {y(tu)}
m
u=1 ) =
∑m
w=1 αm(j,w)∑N
k=1
∑m
w=1 αm(k,w)
15: return {P(X(tm) = j | {y(tw)}
m
w=1)}
N
j=1
16: end procedure
4. Learning Hidden Absorbing Semi-Markov Models
In Section 3.1, we developed an inference algorithm that can handle diagnostic and prog-
nostic tasks for patients in real-time assuming that the true HASMM parameter set Γ is
known. In practice, the parameter set Γ is not known, and has to be learned from an
offline EHR dataset D that comprises D episodes for previously hospitalized or monitored
patients, i.e.
D =
{
{ydm, t
d
m}
Md
m=1, T
d
c , l
d
}D
d=1
,
where {ydm, t
d
m}
Md
m=1 are the observable variables and their respective sampling times for the
dth episode, T dc is the episode’s censoring time, and l
d ∈ {1, N} is a label for the realized
absorbing state.
We note that unlike the conventional HMM learning setting (Rabiner (1989); Zhang et al.
(2001); Nodelman et al. (2012)), the episodes are not of equal-length as the observations
for every episode stop at a random, but informative, censoring time. Thus, the patient’s
state trajectory does not manifest only in the observable time series, i.e. {ydm, t
d
m}
Md
m=1, but
also in the episode’s censoring variables {T dc , l
d}. In this Section, we develop an efficient
algorithm, which we call the forward-filtering backward-sampling Monte Carlo EM (FFBS-
MCEM) algorithm, that computes the Maximum Likelihood (ML) estimate of Γ given an
informatively censored dataset D, i.e. Γ∗ = arg maxΓ Λ(D |Γ), where Λ(D |Γ) = dP(D |Γ)
is the likelihood of the dataset D given the parameter set Γ. We start by presenting the
learning setup in Section 4.1, and then we present the FFBS-MCEM algorithm Section 4.3.
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4.1 The Learning Setup
We focus on the challenging scenario when no domain knowledge or diagnostic assessments
for the patients’ latent states are provided in the dataset 17 D (with the exception of the
absorbing state which is declared by the variable ld), i.e. the learning setup is an unsu-
pervised one. For such a scenario, the main challenge in constructing the ML estimator Γ∗
resides in the hiddenness of the patients’ state trajectories in the training dataset D; the
dataset D contains only the sequence of observable variables, their respective observation
times, the episodes censoring time and the state in which the trajectory was absorbed.
If the patients’ latent state trajectories (X(t))t∈R+ were observed in D, the ML estima-
tion problem Γ∗ = argmaxΓ P(D |Γ) would have been straightforward; the hiddenness of
(X(t))t∈R+ entails the need for marginalizing over the space of all possible latent trajectories
conditioned on the observed variables, which is a hard task even for conventional continuous-
time HMM models (Liu et al. (2015); Nodelman et al. (2012); Leiva-Murillo et al. (2011);
Metzner et al. (2007)).
In order to construct the ML estimator for Γ, we start by writing the complete likelihood,
i.e. the likelihood of an HASMM with a parameter set Γ to generate both the hidden states
trajectory {xdn, s
d
n}
kd
n=1 and the observable variables {y
d
m, t
d
m}
Md
m=1 for the d
th episode in the
dataset D as follows
dP
(
{xdn, s
d
n}
kd
n=1, {y
d
m, t
d
m}
Md
m=1
∣∣∣ Γ) = P(xd1|Γ) · dP(sd1|xd1,Γ) · dP({ydm, tdm}tdm∈T d1 |xd1,Γ)×
kd∏
n=2
P(xdn |x
d
n−1, s
d
n−1,Γ) · dP(s
d
n |x
d
n,Γ) · dP({y
d
m, t
d
m}tdm∈T dn |x
d
n,Γ), (19)
where kd is the number of states that realized in episode d from t = 0 until absorp-
tion. The factorization in (19) follows from the conditional independence properties of
the HASMM variables (see Figure 6). Since we cannot observe the latent states trajec-
tory {xdn, s
d
n}
kd
n=1, the ML estimator deals with the expected likelihood Λ(D |Γ), which is
evaluated by marginalizing the complete likelihood over the latent states trajectories, i.e.
Λ(D |Γ) = Ex(t)|D,Γ
[
D∏
d=1
dP({xdn, s
d
n}
kd
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ)
]
=
D∏
d=1
Exd(t)|D,Γ
[
dP({xdn, s
d
n}
kd
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ)
]
=
D∏
d=1
∫
dP({xdn, s
d
n}
kd
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ) · dP({x
d
n, s
d
n}
kd
n=1 | D, Γ), (20)
17. For some settings, such as chronic kidney disease progression estimation (Eddy and Neilson (2006)), the
EHR records may include some anchors or assessments to the latent states over time. A simpler version
of the learning algorithm proposed in this Section can be used to deal with such datasets. In critical care
settings, it is more common that the EHR records are not labeled with any clinical state assessments
over time (Yoon et al. (2016)).
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where we have assumed that the episodes in D are independent and identically distributed.
The integral in (20) can be further decomposed as follows
Λ(D |Γ) =
D∏
d=1
∫
P(xd1|Γ) · dP(s
d
1|x
d
1,Γ) · dP({y
d
m, t
d
m}tdm∈T d1
|xd1,Γ) · dP({x
d
n, s
d
n}
kd
n=1 | D, Γ)
×
kd∏
n=2
P(xdn |x
d
n−1, s
d
n−1,Γ) · dP(s
d
n |x
d
n,Γ) · dP({y
d
m, t
d
m}tdm∈T dn |x
d
n,Γ). (21)
4.2 Challenges Facing the HASMM Learning Task
The problem of learning the HASMM parameters by maximizing the likelihood function in
(21) is obstructed by various obstacles that hinder the deployment of off-the-shelf learning
algorithms; we list these challenges hereunder.
1. Finding the ML estimate Γ∗ by direct maximization of Λ(D |Γ) is not viable due
to the intractability of the integral in (21), i.e. Λ(D |Γ) has no analytic maximizer.
The difficulty of evaluating the expected likelihood Λ(D |Γ) follows from the need to
average the complete likelihood over a complicated posterior density function for the
latent state trajectory.
2. Direct adoption of the conventional Baum-Welch implementation of the EM algorithm
as a solution to the intractable problem of maximizing the expected likelihood in (21)
–as has been applied in HMMs (Rabiner (1989)), HSMMs (Murphy (2002)), EDHMMs
and VDHMMs (Yu (2010)– is not possible for the HASMM setting. This is due to the
intractability of the integral involved in the E-step; a problem that is also faced by
other continuous-time models (Liu et al. (2015); Nodelman et al. (2012)). However,
these models assumed Markovian state trajectories, in which case the implementation
of the E-step boils down to computing the expected state durations and transition
counts as sufficient statistics for estimating the latent trajectories18 (e.g. see Equations
(12) and (13) in (Liu et al. (2015))). This simplification, which follows from the
plausible properties of the Markov chain’s transition rate matrix, does not materialize
for semi-Markovian transitions. Further complications are introduced by the duration-
dependence of the state-transitions and the segmental nature of the observables.
3. Learning an informatively censored dataset would naturally benefit from the informa-
tion conveyed in the censoring variables {T dc , l
d}. However, the availability of censor-
ing information leads to more complicated posterior density expressions for the latent
18. Different approaches have been developed in the literature for computing these quantities: (Wang et al.
(2014)) assumes that the transition rate matrix is diagonalizable, and hence utilize a closed-form esti-
mator for the transition rates, whereas (Liu et al. (2015)) uses the Expm and Unif methods (originally
developed in (Hobolth and Jensen (2011))) to evaluate the integrals of the transition matrix exponential.
Unfortunately, none of these methods could be utilized for computing the proximal log-likelihood of an
HASMM due to the semi-Markovianity of the state trajectory (i.e. state-durations are not exponentially
distributed as it is the case in (Liu et al. (2015); Nodelman et al. (2012); Hobolth and Jensen (2011);
Wang et al. (2014))).
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state trajectories, which complicates the job of any analytic, variational or Monte
Carlo based inference method one would use to infer the latent state trajectories19.
In the following Section, we present a learning algorithm that addresses the above challenges,
and provides insights into general settings in which informatively censored time series data
are to be dealt with.
4.3 The Forward-filtering Backward-sampling Monte Carlo EM Algorithm
4.3.1 Expectation-Maximization
As in the case of classical discrete and continuous-time HMMs, we address the first challenge
stated in Section 4.2 by using the EM algorithm (Liu et al. (2015); Nodelman et al. (2012)).
The iterative EM algorithm starts with an initial guess Γˆo for the parameter set, and
maximizes a proxy for the log-likelihood in the zth iteration as follows:
• E-step: Q(Γ; Γˆz−1) =
∑D
d=1 E
[
log(P({xdn, s
d
n}
kd
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ))
∣∣∣ D, Γˆz−1] .
• M-step: Γˆz = arg maxΓ Q(Γ; Γˆ
z−1).
The E-step computes the proximal expected log-likelihood Q(Γ; Γˆz−1), which entails evalu-
ating the following integral
Q(Γ; Γˆz−1) =
D∑
d=1
∫
log(dP({xdn, s
d
n}
kd
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ)) · dP({x
d
n, s
d
n}
kd
n=1 | D, Γˆ
z−1),
where dP({xdn, s
d
n}
kd
n=1 | D, Γˆ
z−1) = dP({xdn, s
d
n}
kd
n=1 | {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) = l
d, Γˆz−1). That
is, the proximal expected log-likelihood Q(Γ; Γˆz−1) is computed by marginalizing the like-
lihood of the observed samples of the dth episodes {ydm, t
d
m}
Md
m=1 over all potential latent
paths (xd(t))t∈R+ that are censored at time T
d
c and absorbed in state l
d. Figure 9 depicts a
set of observables ({ydm, t
d
m}
Md
m=1, x
d(T dc ) = l
d) for one episode, and a potential latent path
{xdn, s
d
n}
kd
n=1 that could have generated such observables. Computing Q(Γ; Γˆ
z−1) requires av-
eraging over the posterior density of the latent paths conditional on an observable episode.
4.3.2 “The Only Good Monte Carlo is a Dead Monte Carlo”
Since computing Q(Γ; Γˆz−1) does not admit a closed-form solution, as mentioned earlier in
the second challenge stated in Section 4.2, we resort to a Monte Carlo approach for approxi-
mating the integral involved in the E-step (Caffo et al. (2005)). That is, in the zth iteration
of the EM algorithm, we draw G random trajectories ({xd,gn , s
d,g
n }k
d,g
n=1)
G
g=1 for every episode
d, and use those trajectories to construct a Monte Carlo approximation QˆG(Γ; Γˆ
z−1) for the
19. Note that the censoring information are only (causally) available in the model training (learning) phase
since we deal with an offline batch of data through which we can see the full patients’ episodes, whereas
real-time inference, discussed in the previous Section, does not take advantage of any external censoring
information since this information cannot be causally provided to our algorithms.
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Time tt7t6t5t4t3t2t1t = 0
{Xn}
K
n=1
t8
l = N
Tc
T2 = ∅ T3 = {t4, t5}T1 = {t1, t2, t3}
T4 = {t6, t7, t8}
{Y (tm)}
8
m=1
Figure 9: An episode that comprised 8 observable samples, censored at time Tc, and absorbed in state
N (catastrophic state). The dashed state trajectory is a trajectory that could have generated the
observables with a positive probability. Computing the proximal log-likelihood requires averaging
over infinitely many paths that could have generated the observables with a positive probability.
proximal log-likelihood function Q(Γ; Γˆz−1). Sample trajectories are drawn from the poste-
rior density of the latent states’ trajectory conditional on the the observable variables (in-
cluding the censoring information). That is to say, the gth sample trajectory {xd,gn , s
d,g
n }k
d,g
n=1
is drawn as follows
{xd,gn , s
d,g
n }
kd,g
n=1 ∼ dP({x
d
n, s
d
n}
kd
n=1 | {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) = l
d, Γˆz−1), (22)
for g ∈ {1, . . ., G}. Hence, the proximal log-likelihood Q(Γ; Γˆz−1) can be approximated via
a Monte Carlo estimate QˆG(Γ; Γˆ
z−1) as follows
QˆG(Γ; Γˆ
z−1) ,
D∑
d=1
1
G
G∑
g=1
log(dP({xd,gn , s
d,g
n }
kd,g
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ)). (23)
It follows from the Glivenko-Cantelli Theorem (Durrett (2010)) that
||Q(Γ; Γˆz−1)− QˆG(Γ; Γˆ
z−1) ||∞ = sup
Γ
|Q(Γ; Γˆz−1)− QˆG(Γ; Γˆ
z−1) | → 0 a.s.,
and hence the Monte Carlo implementation of the E-step becomes more accurate as the
sample size G increases. Sampling trajectories from the posterior distribution specified in
(22) in order to obtain a Monte Carlo estimate for Q(Γ; Γˆz−1) is not a straight forward task;
the sampler needs to jointly sample the states and their sojourn times taking into account
the duration-dependent transitions among states, and that the number of variables sampled
(number of states) kd,g in each trajectory is itself random.
Since there is no straightforward method that can generate samples for the random
state trajectory {xdn, s
d
n}
kd
n=1 from the joint posterior density in (22), the normative solution
for such a problem is to resort to a Markov Chain Monte Carlo (MCMC) method such
as Metropolis-Hastings or Gibbs sampling (Carter and Kohn (1994)). Since the number of
state and sojourn time variables, kd, is itself random, one can even resort to a reversible jump
MCMC method (Green and Hastie (2009)) in order to generate the samples for {xdn, s
d
n}
kd
n=1.
At this point of our analysis, we invoke the classical aphorism with which we titled this Sub-
section: “The Only Good Monte Carlo is a Dead Monte Carlo” (Trotter and Tukey (1956)).
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By this quote, Trotter meant to advocate the view that sophisticated Monte Carlo meth-
ods should be avoided whenever possible; whenever an integral is analytically tractable, or
whenever some analytic insights can be exploited to built simpler samplers, doing so should
be preferred to an expensive Monte Carlo method. MCMCs are indeed expensive: they
mix very slowly and they generate correlated samples. Adopting an MCMC to generate
random state trajectories in every iteration of the EM algorithm and for every episode in
D is beyond affordable. Fortunately, in the rest of this Section we show that an efficient
sampler that generates independent samples of {xdn, s
d
n}
kd
n=1 and for which the run-time
is geometrically distributed can be constructed by capitalizing on the censoring informa-
tion and utilizing some insights from the literature on sequential Monte Carlo smoothing
(Godsill et al. (2012)).
4.3.3 The Forward-filtering Backward-sampling Recipe
The availability of the censoring information (censoring time Tc and absorbing state x
d(Tc) =
ld) for every episode d in D, together with the inherent non-linearity of the semi-Markovian
transition dynamics encourage the development of a forward-filtering backward-sampling
(FFBS) Monte Carlo algorithm20 that goes in the reverse-time direction of every episode by
starting from the censoring instance, and sequentially sampling the latent states conditioned
on the (sampled) future trajectory (Godsill et al. (2012)). That is, unlike the generative
process (described by the routine GenerateHASMM(Γ)) which uses the knowledge of Γ to
generate sample trajectories by drawing an initial state and then sequentially going forward
in time and sampling future states until absorption, the inferential process naturally goes
the other way around: it exploits informative censoring by starting from the (known) final
absorbing state (and censoring time), and sequentially samples a trajectory by traversing
backwards in time and conditioning on the future.
We start constructing our forward-filter backward-sampler by first formulating the pos-
terior density of the latent trajectory {xdn, s
d
n}
kd
n=1 (from which we sample the G trajectories
in the zth iteration of the FFBS-MCEM algorithm as shown in (22)) as follows
dP({xdn, s
d
n}
kd
n=1 | {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) = l
d, Γˆz−1) =
dP(sd
kd
| {ydm, t
d
m}
Md
m=1, x
d(T dc ) = l
d) ·
kd−1∏
n=1
dP(xdn, s
d
n | {x
d
n
′ , sd
n
′}k
d
n
′=n+1︸ ︷︷ ︸
Future trajectory
, {ydm, t
d
m}
Md
m=1, T
d
c ),
(24)
where the conditioning on the (z − 1)th guess of the parameter set, Γˆz−1, is suppressed
for notational convenience. The formulation in (24) decomposes the posterior density of
the latent trajectory {xdn, s
d
n}
kd
n=1 into factors in which the likelihood of every state n is
conditioned on the future trajectory starting from n (i.e. the states xdn+1 up to the absorbing
states, together with their corresponding sojourn times). The posterior density in (24) can
20. The methods used in this Section are also known in the literature as sequential Monte Carlo or particle
filtering methods (Godsill et al. (2012)).
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be further decomposed as follows
dP({xdn, s
d
n}
kd
n=1 | {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) = l
d) = dP(sdkd |x
d
kd = l
d, sdkd < T
d
c )×
kd−1∏
n=1
dP(xdn, s
d
n | {x
d
n
′ , sd
n
′}k
d
n
′=n+1
, sdn < T
d
c − (s
d
n+1 + . . . + s
d
kd
)︸ ︷︷ ︸
Elapsed time in the episode
, {ydm, t
d
m}
Md
m=1), (25)
which, using the conditional independence properties of the HASMM (see Figure 6), can be
simplified as follows
dP({xdn, s
d
n}
kd
n=1 | {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) = l
d) =
dP(sdkd |x
d
kd = l
d, sdkd < T
d
c ) · P(x
d
1 |x
d
2, s
d
1 = T
d
c − (s
d
2 + . . . + s
d
kd), {(y
d
m, t
d
m) : t
d
m ∈ T
d
1 })×
kd−1∏
n=2
dP(xdn, s
d
n |x
d
n+1, s
d
n < T
d
c − (s
d
n+1 + . . . + s
d
kd
)︸ ︷︷ ︸
Elapsed time in the episode
, {(ydm, t
d
m) : t
d
m ∈ T
d/ ∪k
d
n
′=n+1
T d
n
′}︸ ︷︷ ︸
Observable variables up to state n
).
(26)
From (26), we can see that for the last state in every episode d, i.e. state kd, we already know
that xd
kd
= ld, and hence the randomness is only in the last state’s sojourn time sd
kd
= ld.
Contrarily, for the first state, we know that conditioned on the sojourn times of the “future
states” (sd2, . . . , s
d
kd
), the sojourn time of state xd1 is equal to T
d
c −
∑kd
n
′=2 s
d
n
′ almost surely,
and hence the randomness is only in the initial state realization xd1. Generally, (26) says
that a sufficient statistic for the nth state and sojourn time is the future trajectory (starting
from state n + 1) summarized by: the next state, i.e. xdn+1, the observable variables up
to state n, and the time elapsed in the episode up to state n, i.e. the duration of state n
cannot exceed the difference between the censoring time T dc and the sojourn time of the
future trajectory that stems from state n + 1. This is captured by the last factor in (26),
which explicitly specifies the likelihood of a joint realization for a state and its sojourn time
conditioned on the future trajectory. Using Bayes’ rule, we can further represent the last
factor in (26) in terms of familiar quantities that are directly derived from the HASMM
model parameters as follows
dP(xdn, s
d
n |x
d
n+1, s
d
n < T
d
c − (s
d
n+1 + . . . + s
d
Kd), {(y
d
m, t
d
m) : t
d
m ∈ T
d/ ∪k
d
n
′
=n+1
T d
n
′})
∝ P(xdn | {(y
d
m, t
d
m) : t
d
m ∈ T
d/ ∪k
d
n
′=n+1
T d
n
′})︸ ︷︷ ︸
Forward message
× P(xdn+1 |x
d
n, s
d
n)︸ ︷︷ ︸
Transition function
×
dP(sdn |x
d
n, s
d
n < T
d
c − (s
d
n+1 + . . . + s
d
kd))︸ ︷︷ ︸
Truncated sojourn time distribution
. (27)
Thus, a sampler for the latent states trajectories can be constructed using the forward
messages, the HASMM’s transition functions (gij(s))i,j , and the sojourn time distributions.
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A compact representation for the factors in (27) is given by
(Forward messages) P(Xdn = j | {y
d
m
′ , td
m
′}m
m
′
=1
, Γˆz−1) = αd,z−1m (j), ∀1 ≤ m ≤M
d, j ∈ X .
(Transition functions) P(Xdn+1 = j |X
d
n = i, S
d
n = s, Γˆ
z−1) = gz−1ij (s), i, j ∈ X ,
(Truncated sojourn times) dP(Sdn = s |X
d
n = j, S
d
n < s¯) =
vj(s|λˆ
z−1
j ) · 1{s<s¯}
Vj(s¯|λˆ
z−1
j )
, j ∈ X .
Given the representations above, we can write the last factor in (26) in the zth iteration of
the EM algorithm as follows
dP(xdn, s
d
n |x
d
n+1, s
d
n < s¯, {y
d
m, t
d
m}, Γˆ
z−1) ∝ αd,z−1m (x
d
n) · g
z−1
xdn,x
d
n+1
(sdn) ·
vxdn(s
d
n|λˆ
z−1
xdn
) · 1{sdn≤s¯}
Vxdn(s¯|λˆ
z−1
xdn
)
.
(28)
From the factor decomposition in (27), we can see that informative censoring allows
us to construct a sampler for the latent state trajectories that operates sequentially in the
reverse time direction by sampling from the posterior probability of every state n given
the future trajectory of states that starts from state n + 1. From (28), we note that
the posterior density of the latent states conditioned on the future trajectory, from which
sequential sampling is conducted, can be explicitly decomposed in terms of the HASMM
parameters. A complete recipe for the forward-filtering backward-sampling procedure for
sampling trajectories from the posterior density dP({xdn, s
d
n}
kd
n=1 | {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) =
ld, Γˆz−1) using the decomposition in (27) and the posterior density in (28) is provided as
follows:
• Forward filtering pass:
For every episode d in D, compute the forward messages {αd,z−1m (j)} for all time
instances tdm ∈ T
d using the current estimate for the parameter set Γˆz−1, i.e. invoke
the routine ForwardFilter(Γˆz−1, {ydm, t
d
m}
Md
m=1, ǫ).
• Backward sampling pass:
For every episode d in D, carry out the following steps:
1. Set a dummy placeholder index as k# = 1 and set uk# = l
d.
2. Sample a Bernoulli random variableBk# ∼ Bernoulli(P(k
d = k# | {uk, wk}
k#−1
k=1 , l
d)).
3. If Bk# = 0 and k
# > 1, sample a bivariate random variable (uk# , wk#) as follows
(uk# , wk#) ∼
1
U

αd,z−1m (uk#) · gz−1u
k#
,u
k#−1
(wk#) ·
vu
k#
(wk# |λˆ
z−1
u
k#
) · 1{wk#≤s¯}
Vu
k#
(s¯|λˆz−1u
k#
)

 ,
where U =
∑
u
∫
w
αd,z−1m (u) · gz−1u,u
k#−1
(w) ·
vu(w|λˆ
z−1
u ) ·1{w≤s¯}
Vu(s¯|λˆ
z−1
u )
, s¯ = T dc −
∑k#−1
n
′=1
wn′ ,
and m = arg maxm′ {T : tm′ ≤ s¯}. If Bk# = 0 and k
# = 1, then sample wk# as
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Algorithm 4 Truncated Rejection Sampler
1: procedure TRSampler(Γ, u, s¯)
2: Input: A parameter set Γ, a state u and a truncation threshold s¯
3: Output: A random variable s
4: k ← 0
5: while k = 0 do
6: s ∼ vu(s|λu)
7: Accept s and set k ← 1 if s < s¯. Reject s otherwise.
8: end while
9: return s
10: end procedure
Algorithm 5 Bivariate Adaptive Rejection Sampler
1: procedure BARSampler({α(j)}Nj=1, Γ, u
′
, w¯)
2: Input: A set of N forward messages {α(j)}Nj=1, parameter set Γ, and a state u
′
3: Output: A bivariate conditional random variable (u,w)|u
′
4: k ← 0
5: while k = 0 do
6: u ∼ Multinomial(α(1), . . ., α(N))
7: w = TRSampler(Γ, u, w¯)
8: u˜ ∼ Multinomial(gu1(w), . . ., guN (w))
9: Accept (u,w) and set k ← 1 if u˜ = u
′
. Reject (u,w) otherwise.
10: end while
11: return (u,w)
12: end procedure
follows
wk# ∼
vu
k#
(wk# |λˆ
z−1
u
k#
) · 1{wk#≤T dc }
Vu
k#
(T dc |λˆ
z−1
u
k#
)
.
4. If Bk# = 1, then set wk# = s¯. If k
# > 1, then sample uk# as follows
uk# ∼
dP({yd
m
′ , td
m
′ }m
m
′
=1
|uk#) · guk# ,uk#−1(s¯) · vuk# (s¯|λˆ
z−1
u
k#
) · pˆo,z−1u
k#∑
u dP({y
d
m
′ , td
m
′ }m
m
′=1
|u) · gu,u
k#−1
(s¯) · vu(s¯|λˆ
z−1
u ) · pˆ
o,z−1
u
.
5. If Bk# = 0, then increment the placeholder index k
# and go to step 2 and repeat
the consequent steps.
6. If Bk# = 1, then set k
d = k# and terminate the sampling process for episode
d. Set the sampled trajectory by swapping the bivariate sequence (uk# , wk#) as
follows: (xdn, s
d
n) = (uk#−n+1, wk#−n+1),∀n ∈ {1, . . ., k
#}.
The forward-filtering backward-sampling procedure constitutes of a forward pass in
which we compute the forward messages for all the data points in D using the dynamic pro-
gramming algorithms presented in Section 3, and a backward pass in which these forward
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Algorithm 6 A sampler for latent state trajectories
1: procedure BackwardSampling(Γ, {{αd,om (j)}m,j}d, {y
d
m, t
d
m}
Md
m=1, x
d(T dc ) = l
d)
2: Input: Parameter Γ, forward messages, observables, and censoring information
3: Output: A sampled latent state trajectory {xdn, s
d
n}
kd
n=1
4: k# ← 1, uk# ← l
d, Bk# ∼ Bernoulli(P(k
d = k#|{ydm, t
d
m}
Md
m=1, x
d(T dc ) = l
d))
5: if Bk# = 0 then
6: wk# = TRSampler(Γ, uk#, T
d
c )
7: k# ← k# + 1
8: else
9: wk# = T
d
c , k
d = 1, {xd1, s
d
1} ← {uk# , wk#}
10: Terminate BackwardSampling.
11: end if
12: while k# > 0 do
13: Bk# ∼ Bernoulli(P(k
d = k#|{uk, wk}
k#−1
k=1 , {y
d
m, t
d
m}
Md
m=1))
14: s¯ = T dc −
∑k#−1
n
′=1
wk#
15: if Bk# = 0 then
16: (uk# , wk#)← BARSampler({α
d,o
m (j)}j ,Γ, uk#−1, s¯)
17: k# ← k# + 1
18: else
19: Sample the initial state uk#, set wk# ← s¯
20: {xdn, s
d
n} = {uk#−n+1, wk#−n+1}, ∀n ∈ {1, . . ., k
#}
21: k# ← −1
22: end if
23: end while
24: return {xdn, s
d
n}
kd
n=1
25: end procedure
messages are used to sample latent state trajectories. The backward sampling procedure
for every episode goes as follows. We start from the censoring time at which we know what
state has actually materialized, i.e. the absorbing state. Since we do not know the number
of states in the state trajectory, we initialize a placeholder index k# = 1 as an index for the
absorbing state, and increment it whenever a new state is sampled. We start the sampling
procedure as follows. Given the the censoring variables and the observable time series, we
sample the sojourn time of the last state (the absorbing state): this is sampled from a trun-
cated sojourn time distribution, with a truncation threshold at T dc , and a point mass at T
d
c
with an assigned measure that is equal to the posterior probability of the absorbing state
being the initial state as depicted in Figure 10. This is implemented by first sampling a
Bernoulli random variable Bk# with a success probability equal to the posterior probability
of the absorbing state being the initial state, and then sampling the truncated sojourn time
if Bk# = 0 using the simple rejection sample executed by the routine TRSampler which
is provided in Algorithm 4. Having sampled the last state’s sojourn time, we sample the
penultimate state and its sojourn time jointly using the routine BARSampler (Algorithm
5) as depicted in Figure 11. The routine BARSampler uses a sampling algorithm, that we
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Algorithm 7 Forward-filtering Backward-sampling Monte Carlo EM Algorithm
1: procedure FFBS-MCEM(D, G, ǫ)
2: Input: A dataset D, number of Monte Carlo samples G, and a precision level ǫ
3: Output: An estimate Γˆ for the HASMM parameters
4: Set an initial value Γˆo for the HASMM parameters
5: {αd,om }
Md
m=1 = ForwardFilter(Γˆ
o, {ydm, t
d
m}
Md
m=1, ǫ), ∀1 ≤ d ≤ D ⊲ Forward pass
6: for d = 1 to D do ⊲ Backward pass: sample G latent state trajectories
7: for g = 1 to G do
8: {xd,gn , s
d,g
n }k
d,g
n=1 = BackwardSampling(Γˆ
o, {ydm, t
d
m}
Md
m=1, x
d(T dc ) = l
d)
9: end for
10: end for
11: z ← 1
12: E ← ǫ+ 1
13: while E > ǫ do
14: Iz−1d,g ← dP({x
d,g
n , s
d,g
n }k
d,g
n=1 | Γˆ
z−1)/dP({xd,gn , s
d,g
n }k
d,g
n=1 | Γˆ
o) ⊲ Importance weights
15: QˆG(Γ; Γˆ
z−1) =
∑
d,g log(dP({x
d,g
n , s
d,g
n }k
d,g
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ)) ·
Iz−1
d,g
G
⊲ E-step
16: Γˆz = arg maxΓ QˆG(Γ; Γˆ
z−1) ⊲ M-step
17: z ← z + 1
18: end while
19: return Γˆ = Γˆz
20: end procedure
call the bivariate adaptive rejection sampler, which jointly samples the current state and its
sojourn time given the next state as follows. First, a state is sampled from a Multinomial
distribution with probability masses equal to the forward messages. Next, given the sam-
pled state, we sample a sojourn time from the truncated sojourn time distribution. Finally,
given the sampled state and the sampled sojourn time, we sample a dummy state from a
Multinomial whose masses are equal to the transition functions, and we accept the sample
only if the sampled dummy state is equal to the next state. It can be easily proven that
BARSampler generates samples that are equal in distribution to the true state trajectory.
The backward-sampling procedure operates sequentially by invoking the BARSampler
to generate new state and sojourn times samples conditional on the previously sampled
(future) states. The process terminates whenever Bk# = 1, i.e. a state is sampled as
an “initial state”. The routine BackwardSampling (Algorithm 6) implements the overall
backward-sampling procedure for every episode in D.
Note that, unlike the slowly mixing MCMC methods, the backward-sampling algorithm
can generate the latent state trajectory in an efficient manner, i.e. the run-time of the
backward-sampling algorithm is stochastically dominated by a geometrically-distributed
random variable with a success probability that, other than in a pathological HASMM pa-
rameter settings, would not be close to zero. Moreover, since BackwardSampling generates
independent samples, no wasteful burn-in sampling iterations are involved in the FFBS-
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Figure 10: Depiction of the backward sampling pass for the last state of an episode d.
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Figure 11: Depiction of the backward sampling pass for the penultimate state after having sampled
the last state as depicted in the Figure above.
MCEM operation. We provide a pseudocode for the overall operation of the FFBS-MCEM
algorithm in Algorithm 7. We omit the standard EM operations, such as the implementa-
tion of the M-step, for the sake of brevity.
In Algorithm 7, we avoid the need for running the routine BackwardSampling in every
iteration of the EM algorithm by re-using the sampled trajectories based on the initial pa-
rameter guess Γˆo through the usage of importance weights in the E-step. That is, in the
zth iteration of the EM algorithm, we implement the E-step as follows (Booth and Hobert
(1999))
QˆG(Γ; Γˆ
z−1) =
∑
d,g
log(dP({xd,gn , s
d,g
n }
kd,g
n=1, {y
d
m, t
d
m}
Md
m=1 |Γ)) ·
dP({xd,gn , s
d,g
n }k
d,g
n=1 | Γˆ
z−1)
dP({xd,gn , s
d,g
n }k
d,g
n=1 | Γˆ
o)︸ ︷︷ ︸
Importance weights
.
This implementation for the E-step offers a tremendous advantage in the computational
cost of FFBS-MCEM. By using importance weights, we need to compute the forward messages
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and sample the latent state trajectories only once, and then reuse the sampled trajectories
in all the subsequent EM iterations. In the following Theorem, we prove that FFBS-MCEM
is as accurate as an EM algorithm with an exact implementation for the E-step when the
number of Monte Carlo samples G grows asymptotically large.
Theorem 3 (Convergence properties of FFBS-MCEM) The sequence of parameter
set estimates {Γˆz} computed by the FFBS-MCEM algorithm converges in probability, i.e.
Γˆz
p
→ Γ¯. Furthermore, if Γ∗ is a local maximizer of Λ(D|Γ), then there exists a neighborhood
of Γ∗ such that for any initial guess Γˆo in that neighborhood and for any ǫ > 0 we have that
lim
G↑∞
P(||Γˆz − Γ∗|| < ǫ)→ 1.
Proof See Appendix C.
In the next Section, we highlight the merits of our model and the associated algorithms
through experiments conducted on a real-world dataset of informatively censored clinical
time series data.
5. Experiments: Intensive Care Unit Prognostication
We investigate the utility of the HASMM in the setting of ICU prognostication; we use the
HASMM as a model for the physiology of critically ill patients in regular hospital wards who
are monitored for various vital signs and lab tests. Through the HASMM, we construct a
risk score (based on the analysis in Section 3.3) that assesses the risk of clinical deterioration
for the monitored patients, which allows for timely ICU admission whenever clinical decom-
pensation is detected. Risk scoring in hospital wards and ICU admission management is a
pressing problem with a huge social and clinical impact: qualitative medical studies have
suggested that up to 50% of cardiac arrests on general wards could be prevented by earlier
transfer to the ICU (Hershey and Fisher (1982)). Since over 200,000 in-hospital cardiac
arrests occur in the U.S. each year with a mortality rate of 75% (Merchant et al. (2011)),
improved patient monitoring and vigilant care in wards enabled by the HASMM would
translate to a large number of lives saved yearly.
5.1 Data
5.1.1 The Patients’ Cohort
Experiments were conducted on a heterogeneous cohort of 6,094 episodes for patients who
were hospitalized in Ronald Reagan UCLA medical center during the period between March
3rd, 2013 to March 29th, 2016. The patients’ population is heterogeneous: we considered
admissions to all the floors and units in the medical center, those include the acute care pe-
diatrics unit, cardiac observation unit, cardiothoracic unit, hematology and stem cell trans-
plant unit and the liver transplant service. Patients admitted to those floors (or wards) are
post-operative or pre-operative critically ill patients who are vulnerable to adverse clinical
outcomes that may require an impending ICU transfer. The cohort comprised patients
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Figure 12: Visualization for the episodes’ censoring information.
with a wide variety of ICD-9 codes and medical conditions, including leukemia, hyperten-
sion, septicemia, sepsis, abdomen and pelvis, pneumonia, and renal failure. Table 2 shows
the distribution of the most common ICD-9 codes in the patient cohort together with the
corresponding medical conditions. The notable heterogeneity of the cohort suggests that
the results presented in this Section are generalizable to different cohorts extracted from
different hospitals. Every patient in the cohort is associated with a set of 21 (temporal)
physiological streams comprising a set of vital signs and lab tests that are listed in Table
2. The physiological measurements are gathered over time during the patient’s stay in the
ward, and they manifest -in a subtle fashion- the patient’s clinical state. The physiological
measurements are collected over irregularly spaced time intervals (usually ranging from 1
to 4 hours); for each physiological time series, we have access to the times at which each
value was gathered.
In all the experiments hereafter, we split the patient cohort into a training set and a testing
set. The training set comprises 4,939 patients admitted to the medical center in the period
between March 3rd, 2013 to November 1st, 2015; the testing set comprises 1,155 patients
admitted in the period between November 1st, 2015 to March 29th, 2016. This split of
the data allows us to assess the performance under the realistic scenario when a certain
algorithm learns from the data available up to a certain date, and then is used to assess the
risk for patients admitted in future dates. In Table 2, we show statistics for the patients’
baseline static features (e.g. gender, age, etc) in both the training and testing sets; as we
can see, the characteristics of the patients admitted in the period (March 2013 - November
2015) has not significantly changed from those admitted in the period (November 2015 -
March 2016). We have verified this fact using a two-sample t-test through which we com-
pared the expected values of the baseline co-variates in both the training and testing sets.
This means that the hospital’s management policy with respect to the patients’ acceptance
and triaging has not significantly changed across the two time periods, and hence whatever
is learned from the training data can be sensibly applied to the testing data.
5.1.2 Informative Censoring
All the patient episodes in the cohort were informatively censored. That is, for every patient
in the cohort, we know the following information:
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Table 2: Characteristics of the patient cohort under study
Physiological data ICD-9 codes’ distribution
Vital signs Lab tests
Diastolic blood pressure Chloride
786.05 (7%)
401.9 (6%)
38.9 (5%)
995.91 (5%)
789 (5%)
780.6 (5%)
486 (5%)
584.9 (5%)
599 (4%)
780.97 (4%)
285.9 (4%)
786.5 (4%)
585 (3%)
780.79 (3%)
578 (3%)
428 (3%)
427.31 (3%)
787.01 (3%)
Other (22.5%)
Eye opening Glucose
Glasgow coma scale score Urea Nitrogen
Heart rate White blood cell count
Respiratory rate Creatinine
Temperature Hemoglobin
O2 Device Assistance Platelet Count
O2 Saturation Potassium
Best motor response Saturation Sodium
Best verbal response Total CO2
Systolic blood pressure
ICD-9 codes
(786.05) Shortness of Breath
(401.9) Hypertension
(38.9) Septicemia
(995.91) Sepsis
(789) Abdomen and pelvis
(780.6) Fever
(486) Pneumonia
(584.9) Renal failure Baseline Patient Characteristics (with 95% CI)
(599) Urethra and urinary attack • Gender distribution (Male percentage)
(780.97) Altered mental status (Training: 50.31% 1.4% - Testing: 51.16% 2.92%)
(285.9) Anemia • Transfers from other hospitals
(786.5) Chest pain (Training: 11.88% 0.94% - Testing: 11.08% 1.95%)
(585) Chronic renal failure • Average age
(780.79) Malaise and fatigue (Training: 58.9 0.55 years - Testing: 59.37 1.11 years)
(578) Gastrointestinal hemorrhage • Patients with chemotherapy
(428) Heart failure (Training: 0.688% 0.272% - Testing: 1.558% 0.9%)
(427.31) Atrial fibrillation • Patients with stem cell transplants
(787.01) Nausea (Training: 0.121% 0.8% - Testing: 0.008% 0.004%)
3
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• The censoring time (Tc): the length of stay of each patient in the ward is recorded in
the dataset, and hence we have access to the HASMM’s censoring time variable Tc. The
average hospitalization time (or censoring time) in the cohort is 157 hours and 34 minutes
(6.5 days). The patient episodes’ censoring times ranged from 4 hours to 2672 hours.
• The absorbing clinical state (l): with the help of experts from the division of pul-
monary and critical care medicine at Ronald Reagan UCLA medical center, we set the
value of the variable l (absorbing state) for every patient’s episode based on the clinicians’
interventions as reported in the dataset. That is, as advised by our medical collaborators,
we assigned the label l = 1 to every patient who was admitted to the ICU and underwent
an intervention in the ICU (e.g. ventilator, drug, etc), or was reported to exhibit a cardiac
or respiratory arrest (before or after the ICU transfer). According to the medical experts,
those patients have experienced “clinical deterioration” as their absorbing state, and would
have benefited from an earlier admission to the ICU. We have excluded all patients who
underwent a preplanned ICU admission from the dataset since those patients did not ac-
tually experience clinical deterioration, but were transferred routinely to the ICU after a
surgery. We assigned the label l = 0 to all patients who were discharged home after the
clinician’s in charge realized they were clinically stable. Since the readmission rate at the
UCLA medical center is quite low, our medical collaborators believe that the labels l = 1
and l = 0 represent an accurate representation for the patients’ true absorbing clinical states
upon censoring.
Patient episodes with the absorbing state l = 0 had an average censoring time of 155
hours on average, whereas those with l = 1 had an average censoring time of 204 hours.
The percentage of episodes with an absorbing state l = 1 was 4.98% 0.64% in the train-
ing period (March 2013 - November 2015), and was 5.19% 1.44% in the testing period
(November 2015 - March 2016). A two-sample t-test reveals that the censoring information
(distributions of Tc and l) has not significantly changed from the training to testing periods,
which suggests that the HASMM learned from the training data can be sensibly applied to
the testing data. Figure 12 visualizes the informative censoring information over the time
period between March 2013 and March 2016. Every patient episode, starting at a certain
admission date, is represented by its censoring time (hospitalization time); light colored
episodes are ones that were absorbed in the clinical stability state (l = 0), whereas dark
colored ones were absorbed in the clinical deterioration state (l = 1).
5.2 Baseline Algorithms
We compare the HASMM, as a model for the patients’ episodes based on which an early
warning system is constructed, with other baseline early warning methods. The comparisons
involve both state-of-the-art clinical risk scores that are currently used in various healthcare
facilities around the world, in addition to benchmark machine learning algorithms. The
details of the baselines are provided in the following subsections.
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5.2.1 State-of-the-art Clinical Risk Scores
We have conducted comparisons with the most prominent clinical risk scores currently
deployed in major healthcare facilities. We list the clinical risk scores involved in our
comparisons as follows.
(i) Modified Early Warning System (MEWS): a risk scoring scheme used currently
by many healthcare facilities and rapid response teams to quickly assess the severity of
illness of a hospitalized patient (Morgan et al. (1997)). The score ranges from 0 to 3
and is based on the following cardinal vital signs: systolic blood pressure, respiratory
rate, SaO2, temperature, and heart rate.
(ii) Sequential Organ Failure Assessment (SOFA): a risk score (ranging from 1
to 4) that is used to determine the extent of a hospitalized patient’s respiratory,
cardiovascular, hepatic, coagulation, renal and neurological organ function in the ICU
(Vincent et al. (1996)).
(iii) Acute Physiology and Chronic Health Evaluation (APACHE II): a risk scor-
ing system (an integer score from 0 to 71) for predicting mortality of patients in the
ICU (Knaus et al. (1991)). The score is based on 12 physiological measurements,
including creatinine, white blood cell count, and glasgow coma scale.
(iv) Rothman Index: a regression-based data-driven risk score that utilizes physiological
data to predict mortality, 30-days readmission, and ICU admissions for patients in
regular wards (Rothman et al. (2013)). The Rothman index is the state-of-the-art
risk score for regular ward patients and is currently used in more than 70 hospitals in
the US, including the Houston Methodist hospital in Texas and the Yale-New Haven
hospital in Connecticut (Landro (2015)). At the time of conducting these experiments,
the Rothman index was also deployed in the Ronald Reagan UCLA medical center.
We implemented the MEWS, SOFA, APACHE II and Rothman scores according to the
specifications in (Vincent et al. (1996); Knaus et al. (1991); Rothman et al. (2013)). Note
that while the SOFA and APACHE II scores are usually deployed for patients in the ICU,
both scores have been recently shown to provide a prognostic utility for predicting clinical
deterioration for patients in regular wards (Yu et al. (2014)), and hence we consider both
scores in our comparisons.
5.2.2 Machine Learning Algorithms
In order to demonstrate the modeling gain of HASMMs, we make comparisons with other
competing machine learning algorithms that adopt different modeling approaches for the
clinical time series data. The details of these competing models are provided in the follow-
ing.
Discriminative models:
We consider the following set of discriminative predictors that directly predict clinical de-
terioration without explicitly modeling the clinical time series data:
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• Logistic regression.
• Least absolute shrinkage and selection operator (LASSO).
• Random forest.
• Recurrent Neural Networks (RNN).
In order to ensure that the censoring information is utilized by all the discriminative pre-
dictors, we train every predictor by constructing a training dataset that comprises the
physiological data gathered within a temporal window before the censoring event (ICU ad-
mission or patient discharge), and using the censoring information (i.e. the variable l) as
the labels. The size of this window is a hyper-parameter that is tuned separately for every
predictor. For the testing data, the predictors are applied sequentially to a sliding window
of every patient’s episode, and the predictor’s output is considered as the patient’s real-time
risk score21. We used the built-in MATLAB functions for training the logistic regression,
LASSO and random forest predictors.
Although RNNs are not clinically interpretable, they have been frequently applied to the
problem of clinical time series prediction, and the recent work in (Che et al. (2016)) have
considered RNNs to predict mortality in the ICU using the MIMIC dataset (Saeed et al.
(2002)). We have trained an RNN with 5 hidden layers, and 10 neurons with each layer,
using the Broyden-Fletcher-Goldfarb-Shanno (BFGS) algorithm22, where gradients are com-
puted using the Backpropagation Through Time algorithm (Werbos (1990)). All the training
time series were temporally aligned via the endpoint censoring information, and training
was accomplished via 1000 iterations of the BFGS algorithm. A top layer with a squashing
sigmoid function was used to map the RNN hidden states to a risk score between 0 and 1
at each point in time.
We used the correlated feature selection algorithm to select the physiological stream for
every predictor (Yu and Liu (2003)). To ensure a fair comparison, we did not include the
static co-variates in any predictor, including the HASMM, since they are not used by the
clinical risk scores.
Generative models:
In addition to the discriminative models, we also considered the following probabilistic
models for the patients’ episodes:
• Hidden Markov Models (HMM) with Gaussian emissions.
• Multi-task Gaussian process.
21. This differs from the static simulation setting in (Ghassemi et al. (2015)) were predictions are issued in
a one-shot fashion using only the data obtained within 24 hours after a patient’s admission.
22. We have also tried the Levenberg-Marquardt algorithm, but the network learned by BFGS offered a
significantly better performance.
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We used the Baum-Welch algorithm for learning the HMM (Murphy et al. (2001)); the
informative censoring information was incorporated by including two absorbing states for
clinical stability (l = 0) and deterioration (l = 1), and informing the forward-backward
algorithm with the labeled states at the end of every episode. We tried many initializations
for the HMM parameters and picked the initialization that led to the maximum likelihood
for the training dataset. The complete data log likelihood after 100 EM iterations was
-1.25× 107. In real-time, a patient’s risk score at every point of time is computed by first
applying forward filtering to obtain the posterior probability of the patient’s states, and
then averaging over the distribution of the absorbing states. Using the Bayesian Informa-
tion Criterion, we selected an HMM model with 4 latent states.
For the multi-task Gaussian process, we used the free-form parametrization in (Bonilla et al.
(2007)), and used the gradient method to learn the parameters of two Gaussian process
models: one for patients with l = 0, and one for patients with l = 1. The risk score for a
patient’s risk score is computed as the test statistic of a sequential hypothesis test that is
based on the two learned Gaussian process models.
5.3 Results
5.3.1 Performance metrics
In order to assess the performance of every algorithm, we compute each algorithm’s risk
score R(t) at every point of time in every patient’s episode. We only use the patient
episodes in the testing set for performance evaluation. The risk score that is based on an
HASMM is evaluated as discussed in Section 3.3. We emulate the ICU admission decisions
by setting a threshold on the risk score R(t) above which a patient is identified as “clinically
deteriorating”. The accuracy of such decisions are assessed via the following performance
metrics: true positive rate (TPR), positive predictive value (PPV) and timeliness. These
performance metrics are formally defined as follows:
TPR =
#patients with l = 1 and R(t) exceeding threshold for some t < Tc
#patients with l = 1
,
PPV =
#patients with l = 1 and R(t) exceeding threshold for some t < Tc
#patients with R(t) exceeding threshold for some t < Tc
,
and
Timeliness = E [Time at which R(t) exceeds threshold− Tc | R(t) exceeds threshold, l = 1] .
The three performance metrics described above evaluate the different risk scoring algorithms
in terms of their detection power, false alarm rate, and timeliness in detecting clinical
deterioration. We sweep the threshold value of every risk scoring algorithm and report
the AUC of the TPR vs. PPV ROC curve. All results reported hereafter are statistically
significant (p-value < 0.001).
5.3.2 Learning the HASMM
We applied the FFBS-MCEM algorithm to the training episodes in order to estimate the
parameter set Γ. Based on the Bayesian information criterion, we have selected a model
42
An HASMM Model for Informatively Censored Temporal Data
with 4 clinical states, i.e. X = {1, 2, 3, 4}. State 1 is the clinical stability state for which
a patient can be discharged, whereas state 4 is the clinical deterioration state at which an
ICU admission is necessary. We ran 100 MCEM iterations and used Γˆ100 as the estimate
for Γ.
We discretized the time domain into steps of 1 hour while computing the elements of the
look-up table holding the values of the tensor P˜. With a granular 1-hour discretization
of the time horizon, the Gaussian covariance matrix was found to be ill-conditioned for
many patient episodes. To ensure the numerical stability of the computations involving the
Gaussian process likelihood functions, we used the Moore-Penrose pseudo-inverse for the
covariance matrix instead of direct matrix inversion. The function TransitionLookUp was
invoked once before running the MCEM iterations, and its run time was 2 minutes and 15
seconds on a dual-core 3 GHz machine. The function ForwardFilter was invoked 150,852
times (all data points in all patients’ episodes in the testing set), and its overall run time
was 3 hours and 50 minutes (on a dual-core 3 GHz machine). The run time for every risk
score update for a single patient is less than 1 second, which implies that the algorithm can
efficiently prompt quick risk assessments if implemented on a machine with a reasonable
computational power.
From the learned HASMM, we were able to extract the following “medical concept” out of
the training data. The patients’ clinical state space X = {1, 2, 3, 4} comprises the following
4 states:
• State 1: clinical stability.
• State 2: type-1 critical state.
• State 3: type-2 critical state.
• State 4: clinical deterioration.
As implied by the model, states 1 and 4 are absorbing states: once the patient is believed
to be in state 1, the clinicians should release her from care, whereas exhibiting clinical state
4 should be treated with an admission to the ICU. States 2 and 3 are critical states that
require the patient to stay under vigilant care in the ward. The two states are different
ways to manifest “criticality”. We characterize the properties of the four clinical states in
the rest of this subsection.
Figures 13-16 depict the different characteristics of the four clinical states. In Figure 13, we
plot a bipartite correlation graph that shows the correlations among the relevant physiolog-
ical streams in the different clinical states. These graphs were constructed by computing
the Pearson correlation coefficient σY lY v =
cov(Y l,Y v)
σ
Y l
· σY v
using the entries of the multi-task
Gaussian process covariance matrix Σ. An edge is connected between every two features
for whom the Pearson correlation coefficient exceeds 0.1, i.e. σY lY v > 0.1. As we can
see, different physiological variables become less or more correlated in the different clinical
states. For instances, only the clinically stable patients experience significant correlations
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Figure 13: Correlations between the patients’ physiological streams in the different clinical states.
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Figure 14: Sojourn time distributions.
−10 −8 −6 −4 −2 0 2 4 6 8 10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Time t
C
o
v
a
r
i
a
n
c
e
f
u
n
c
t
i
o
n
k
i
(
t
)
=
e
−
t
2
2
ℓ
2 i
 
 
i = 4
i = 3
i = 2
i = 1
Figure 15: Covariance functions.
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between their urea Nitrogen and the diastolic blood pressure; the Pearson coefficient be-
tween those variables becomes insignificant in the other states. Clinicians can use this
piece of information, extracted solely from the data, to construct simple tests for clinical
stability by computing the correlations between blood pressure and urea Nitrogen for a
hospitalized patient before deciding to discharge her. Generally speaking, we observe that
the critical, transient states display more correlations among the physiological streams than
the clinical stability and deterioration states. In particular, the type-2 critical state has
most of the physiological streams being strongly correlated. We speculate that the reason
behind these strong correlations is that some kinds of interventions (e.g. drugs, mechanical
pumps, ventilators, etc) applied to hospitalized patients affect all the physiological streams
simultaneously; and hence we believe that type-1 and type-2 critical state patients are hos-
pitalized patients with and without clinical interventions. We will examine this claim when
we retrieve information about interventions and the time they were applied from the Ronald
Reagan medical center; such information was not available at the time of conducting these
experiments.
Figure 14 shows the sojourn time distributions for the four states. Recall that the “so-
journ time” of an absorbing state (state 1 or 4) is defined as the time between entering
the state and the censoring time; such a time interval corresponds to the clinicians’ policy
with respect to patient discharge and ICU admission. That is, the sojourn time of an ab-
sorbing state is not a natural physiological quantity, but it rather reflects the speed with
which patients are released from care or receive leveraged level of care. As we can see,
the sojourn time distributions significantly deviate from an exponential distribution of an
ordinary, memoryless Markov model, which supports our assumption of semi-Markovianity.
Figure 15 displays the covariance function ki(t, t
′
) for the 4 clinical states; the state-specific
covariance function quantifies the physiological streams’ temporal correlations in a par-
ticular clinical conditions. Knowing such correlation patterns are useful for deciding the
frequency with which nurses and clinicians should collect physiological measurements over
time for different patients in different clinical conditions (Alaa and van der Schaar (2016)).
We observed that, as one would expect, the temporal correlations increase when the patient
becomes more stable; the temporal correlation is greatest in state 1 and smallest in state 4.
This means that one would expect deteriorating patients to experience more physiological
fluctuations over time. We also note that physiological stream for which the constant mean
function differed significant among the clinical state was the urea Nitrogen. The level of
urea Nitrogen increases significantly when the patient is in a more risky state; the average
blood urea nitrogen is 11.7 milligrams per deciliter (mg/dL) in state 1, 23.8 mg/dL in state
2, 41.1 mg/dL in state 3 and 64.9 mg/dL in state 4.
Figure 16 depicts the transition functions gij out of the transient states 2 and 3 as a
function of the sojourn time in those states. We note that the transition probabilities are
almost a constant function of sojourn time for patients in state 2 (β2j ≈ 0), whereas the
duration-dependence is more significant (β3j > 0); as the sojourn time in state 3 increases,
the transition probabilities become more biased towards state 1. This reinforces our hy-
pothesis that state 3 corresponds to patients for whom interventions were applied. That
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is, as time passes for a patient in state 3 after receiving an intervention, her chances for
recovery (transiting to state 1) increases.
Now we illustrate the real-time operation of the inference algorithm as it computes risk
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Figure 17: Depiction for the episode of a clinically deteriorating patient.
score over time by focusing on an episode of a particular patient who was hospitalized for
1 day and then admitted to the ICU. As shown in Figure 17 (top), the inference algorithm
computes the forward messages whenever new physiological measurements become avail-
able. Using the forward messages, the algorithm can display the maximum a posteriori
(MAP) state estimates to the clinicians over time. As we can see in Figure 17 (middle),
the patient under consideration was in clinical state 2 (type-1 critical state) at the time
of admission to the ward. After 6 hours, the patient switched to state 3 (type-2 critical
state), probably due to a clinical intervention. After around 9 hours, the patient switched
back to the type-1 critical state for a brief 2-hour period, before switching to the type-2
critical state (probably due to a second intervention). Our algorithm was able to detect
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Table 3: Performance comparisons for various algorithms.
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clinical deterioration (state 4) conclusively (through both the MAP state estimate and the
risk score) more than 6 hours before the clinicians actually sent the patient to the ICU. Had
the clinicians used the algorithm for monitoring that patient, they would have been able
to send the patient to the ICU 6 hours early, allowing for a potentially much more efficient
therapeutic intervention in intensive care. In Figure 17 (bottom), we plot the patient’s
physiological stream and tag the different time intervals with the corresponding clinical
state estimates. The clinicians can rely on these clinically interpretable tags to describe the
patient’s states at each point of time rather than using a high-dimensional, and potentially
inexpressive set of physiological measurements.
5.3.3 Performance comparisons
In order to handle class imbalance, we focused on the TPR vs. PPV performance rather
than the TPR vs. FPR analysis commonly adopted in the medical literature, which over-
looks the class imbalance problem23. We report the AUC values for all the algorithms
under consideration in Table 3. As we can see, all the machine learning algorithms signifi-
cantly outperform the state-of-the-art clinical risk scores (Rothman, MEWS, APACHE and
SOFA). The reason behind the significant performance gain of the HASMM as compared
to the clinical risk scores is that it incorporates the patients’ history when updating the
forward messages (as shown in Figure 17), and reasons about the future trajectory when
computing the risk score (as discussed in Section 3.3). Clinical risk scores are instantaneous
in that they map the current physiological measurements to a risk score without considering
the previously measured physiological variables, and hence they are vulnerable to high false
alarm rates (low PPV). Moreover, the clinical risk scores do not reason about the future
trajectory given the current physiological measurements, and hence they display a sluggish
risk signal that fail to quickly cope with subtle clinical deterioration.
We also note that HASMMs outperforms conventional HMMs; this is a consequence of
incorporating temporal correlations and semi-Markovian state transitions, which more ac-
curately describe the patient’s physiology. This manifests in the sojourn time distributions
in Figure 14, which largely deviate from the exponential distribution adopted by an HMM,
23. Since we focus on the AUC for the TPR vs. PPV, the AUC values are nominally less than that for the
TPR vs. FPR curves. The AUC values in the TPR vs. PPV are usually less than 0.5, whereas in the
TPR vs. FPR analysis they can reach 0.8 (Rothman et al. (2013)).
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and also manifests in the temporal correlation patterns in Figure 15, which largely deviate
from the Dirac-delta function. Moreover, not only that the HASMM outperforms discrim-
inative classifiers that operate on a sliding window of the clinical time series, but unlike
these classifiers, it provides a clinically interpretable model as well (see Figure 17). Such
an interpretable model cannot be provided by discriminative approaches such as logistic re-
gression or RNNs. In addition to the accuracy gains demonstrated in Table 3, we also note
that ICU alarms issued by the HASMM precedes actual ICU admission decisions issued by
the clinicians with 8-9 hours on average for a TPR of 50% and PPV of 35%.
6. Conclusions
We developed a versatile model, which we call the Hidden Absorbing Semi-Markov Model
(HASMM), for clinical time series data which accurately represents physiological data in
modern EHRs. The HASMM can deal with irregularly sampled, temporally correlated, and
informatively censored physiological data with non-stationary clinical state transitions. We
also proposed an efficient Monte Carlo EM learning algorithms that is based on particle
filtering, and developed an inference algorithm that can effectively carry out real-time in-
ferences. We have shown, using a real-world dataset for patients admitted to the Ronald
Reagan UCLA Medical Center, that HASMMs provide a significant gain in critical care
prognosis when utilized for constructing an early warning and risk scoring system.
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Appendix A. Proof of Theorem 1
We start by rewriting (11) as follows:

 p˜11(τ,¯s, s¯) . . . p˜1N (τ,¯s, s¯)... . . . ...
p˜N1(τ,
¯
s, s¯) . . . p˜NN (τ,
¯
s, s¯)

 =

1− Q¯1(τ,¯s, s¯) . . . 0... . . . ...
0 . . . 1− Q¯N (τ,
¯
s, s¯)

+
∫ τ
u=0

 ∂
∂u

 Q¯11(u,¯s, s¯) . . . Q¯1N (u,¯s, s¯)... . . . ...
Q¯N1(u,
¯
s, s¯) . . . Q¯NN (u,
¯
s, s¯)



 ×

 p˜11(τ − u, 0, 0) . . . p˜1N (τ − u, 0, 0)... . . . ...
p˜N1(τ − u, 0, 0) . . . p˜NN (τ − u, 0, 0)

 du.
(29)
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Starting with the left hand side, we can use a first-step analysis to write every term p˜ij(τ,
¯
s, s¯)
as follows
p˜ij(τ,
¯
s, s¯) = P(X(t+ τ) = j|X(t) = i,
¯
s ≤ S(t) ≤ s¯)
= δij (P(Si < τ |X(t) = i,
¯
s ≤ S(t) ≤ s¯))+∫ τ
u=0
P(X(t+ u) = k|X(t) = i,
¯
s ≤ S(t) ≤ s¯) · P(X(t+ τ) = j|X(t + u) = k) du
= δij (1− Q¯i(τ,
¯
s, s¯))+∫ τ
u=0
P(X(t+ u) = k|X(t) = i,
¯
s ≤ S(t) ≤ s¯) · P(X(t+ τ − u) = j|X(t) = k) du
= δij (1− Q¯i(τ,
¯
s, s¯)) +
∫ τ
u=0
∂
∂u
∑
k 6=i
Q¯ik(u,
¯
s, s¯) · p˜kj(τ − u, 0, 0) du, (30)
∀i, j ∈ X , where S(t) is the time elapsed in state X(t), and Si is the sojourn time of state
i. The integral equation in (30) can be written in a matrix form as in the right hand side
of (29), and hence the Theorem follows.
Appendix B. Proof of Theorem 2
Recall that the operation
P˜(τ,
¯
s, s¯) = B{Q¯(τ,
¯
s, s¯)}(P˜(τ,
¯
s, s¯))
can be written as
P˜(τ,
¯
s, s¯) = IN×N − diag
(
Q¯1(τ,
¯
s, s¯), . . . , Q¯N (τ,
¯
s, s¯)
)
+
(
∂Q¯(.,
¯
s, s¯)
∂u
⋆ P˜(., 0, 0)
)
(τ).
Now consider n applications of the operator B(.), we have that(
∂Q¯(.,
¯
s, s¯)
∂u1
⋆ . . . ⋆
∂Q¯(.,
¯
s, s¯)
∂un
⋆ P˜(., 0, 0)
)
(τ) ≤ Nn ·
∫ τ
0
∫ τ−un−1
0
. . .
∫ τ−u1
0
du1 du2. . , dun
= Nn ·
τn
n!
. (31)
Thus, for every P˜(τ,
¯
s, s¯) ∈ P and every Q¯(τ,
¯
s, s¯) < 1, there exists n such that Bn{.}(.) is
a contraction mapping. Therefore, the operation P˜(τ,
¯
s, s¯) = B{Q¯(τ,
¯
s, s¯)}(P˜(τ,
¯
s, s¯)) has a
unique fixed point that can be reached via n ∈ N successive approximations.
Appendix C. Proof of Theorem 3
The Theorem can be proven using the proof of Theorem 5 in (Neath et al. (2013)).
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